Patent Grant
10646405
Many care providers have a pharmacy that prepares medical doses for administration to patients that are treated by the care provider. In this regard, the pharmacies may employ a formulary to prepare medications in order to fulfill medical dose orders that are ordered by care provider personnel (e.g., physicians) for administration to patients. Some medical doses to be prepared may include compounded sterile products (CSPs) that may be prepared in specially constructed and controlled environment (e.g., an “IV Room”) in the pharmacy. The process of preparing medical doses may be carried out in accordance with local policy, governmental regulations, industry organizations (e.g., Chapter <797> of the United States Pharmacopoeia), or other applicable policies. For example, the preparation of medications may generally occur in a laminar airflow hood, isolator, or biological safety cabinet, by an operator (typically a pharmacy technician) who is tasked with preparing the medical doses. Once the medical doses are prepared, the medical doses may be required to be verified by a pharmacist prior to being dispensed from the pharmacy for administration to a patient.
In traditional pharmacy management techniques, medical dose orders may be provided to a printer that prints labels indicative of the medical dose order that are to be applied to finished doses once the doses are prepared. A pharmacy technician may be required to retrieve labels from a label printer and use those labels as work order travelers in the process of preparing each dose. Once the dose prepared, the technician may apply a label to the dose. The completed, labeled dose may be set aside for a pharmacist to check along with, for example, source ingredients, medicament receptacles used in the course of preparing the dose, and/or other material. In this regard, in order to check a dose, the pharmacist may be required to enter the clean room in which the doses are prepared and physically observe the materials associated with the dose order. As such, the checking of prepared doses may require the pharmacist to dress in protective clothing or equipment, which takes time and resources.
Furthermore, the only prompt a pharmacy may receive to prepare a medical dose order is the printing of the label. In this regard, if a label becomes lost or damaged, a dose may not be prepared. Additionally, prioritizing work also becomes difficult because the label stack at the label printer may be the only evidence of what doses have been ordered, prepared, and/or dispensed. As such, relying on physical labels alone to track doses may result in unprepared, lost, or duplicate doses. In some cases, pharmacies may produce duplicate labels as a matter of course such that the pharmacy must review each label against the other, already received labels, to determine if a label represents a new dose order that needs to be prepared. This practice may lead to increased administrative overhead in the pharmacy that add operational costs and reduce pharmacy efficiency.
Furthermore, while instructions for preparation of a drug may be recorded in official FDA-approved literature for the drug, pharmacy technicians may not reliably consult the literature when preparing doses. Rather, pharmacy technicians may memorize the steps needed for the most common drugs, and then generalize those steps to other drugs to be prepared without verifying the protocols associated with a particular drug. In this regard, if the dose order includes special instructions that a pharmacy technician does not recognize, references regarding the proper techniques may not be present or may not be consulted. Accordingly, dose orders including special instructions often must be prepared by more experienced technicians or at the direction of more experienced technicians. In either regard, the protocol used to prepare the dose may not conform to the FDA-approved literature for the drug being prepared.
Further still, in traditional pharmacy management techniques, the pharmacy technician may be responsible for creating records that are maintained in relation to doses that have been prepared and products from the formulary that were employed to make the dose. For example, a pharmacy technician may be tasked with transcribing information such as lot numbers, expiration dates, serial numbers, or the like. The manual creation of records requires labor intensive practices that may result in pharmacy inefficiencies, introduces the potential for errors in the records, and may result in virtually unsearchable paper records.
Embodiments of medical dose preparation management systems that may assist in management of medical doses are described herein. The embodiments described herein may include one or more work stations that are used to assist in preparation of a medical dose order. For example, the work stations may be used to provide guidance to a technician regarding the preparation of a medical dose order, and/or the work order stations may be used to capture, collect, or compile data (e.g., metadata) regarding the medical dose order. In this regard, metadata associated with the medical dose order may be stored in corresponding relation to the medical dose order such that the metadata may be accessible to a care provider before or after administration of the medical dose associated with the medical dose order to the patient. The metadata may include data regarding the prepared dose order, a component of the dose order, or the manner in which the prepared dose order or a component of the dose order was prepared. Accordingly, metadata captured, collected, or compiled at the work station may be used to organize, track, or otherwise manage medical dose orders. As such, examples of advantages facilitated by the medical dose preparation management system may include, among others, improved prioritization, organization, tracking, and records keeping for medical dose orders.
For example, the metadata regarding a dose order may include one or more medical dose preparation images related to components of a medical dose order, steps carried out during the preparation of a dose order, or a finished dose order. In this regard, the medical dose preparation images may be used to document or evidence the preparation of a medical dose order. It may be appreciated that the quality of the medical dose preparation images obtained by the medical dose preparation management system may be an important consideration in the medical dose preparation management system.
As such, it is presently recognized that the features and/or attributes of the work station may contribute to the accuracy, speed, and or quality at which the medical dose orders may be prepared by technicians at the work station while capturing, collecting, and/or compiling metadata (e.g., including medical dose preparation image data). As such, an objective of the present disclosure is to present work stations that facilitate efficient work flows to enable a technician to efficiently prepare medical dose orders while obtaining dose order metadata. Additionally, an objective of the present disclosure is to present work stations that facilitate the capture of high quality medical dose preparation images comprising dose order metadata. In this regard, the efficient capture of high quality dose order metadata during the preparation of a medical dose may contribute to patient safety, improve pharmacy efficiency, assist in pharmacy management, and/or provide other advantages as may be appreciated in the description presented herein. Furthermore, an objective of the present disclosure is to present work stations that may facilitate advantages related to administrative task performed at the work station such as work station cleaning.
Accordingly, a number of aspects are described herein that are related to a medical dose order management system. The various aspects discussed herein may be realized in isolation and/or in combination with one or more others of the aspects presented herein and thereby compose one or more additional aspects. In this application, the term aspect is used synonymous to the term embodiment. In other words, one or more features of one or more aspects and/or one or more features of one or more embodiments described in this application may be separated from the remaining features of the corresponding aspect and/or embodiment and combined with separated features of one or more aspects and/or embodiments to create new aspects and/or embodiments. In this regard, the aspects described herein may be used in the context of a work station of a medical dose management system as described above. In particular, the workstation may be adapted and suitable for the use in a system for medical dose preparation management. One aspect may relate to the use of a workstation for medical dose preparation management. Another aspect may relate to a medical dose management system and the workstation may be a component of the medical dose management system.
Accordingly, the work station may generally include an imaging device (e.g., digital camera) supported relative to a medication preparation staging region. The medical dose preparation staging region may be at least partially defined by a base having a length and a width. That is, the base may include a surface for supporting an object such as a medication receptacle used in the preparation of a medical dose order at the work station. The imaging device may have an imaging field encompassing at least a portion of the medication preparation staging region. The imaging device may be operable to capture digital image data (e.g., still digital images and/or video data stream) of the medical dose preparation staging region (e.g., including medication receptacles used in the medical dose order or prepared by the work station).
In this respect, one aspect may include an imaging device that is located at least partially within a housing. In turn, the imaging field of the imaging device may extend through an opening of the housing. Additionally, a transparent shield may be disposed between the imaging device and the medication preparation staging region. In particular, the transparent shield may cover at least a portion of the imaging device (e.g., corresponding to at least a lens of the imaging device). The transparent shield may extend across at least a portion of or substantially all of the opening through which the imaging field of the imaging device extends.
In the latter regard, the transparent shield and the housing may define an enclosed volume. As such, the transparent shield and the housing may define a continuous outer surface disposed about the enclosed volume. Thus, the imaging device may be disposed within the enclosed volume. As a result, the imaging device may be shielded from an environment external to the enclosed volume (e.g., the camera may be isolated from spills or other potential contact with liquids or hazardous substances such as may occur during dose preparation or during the cleaning of the work station).
In another aspect, an imaging device may be provided having at least one fixed optical setting. In an embodiment, the fixed optical setting may be preset (e.g., during the manufacture of the work station). The fixed optical setting may result in a depth of field that encompasses substantially the entire medical dose preparation staging region (e.g., such that an image of an object in the medical dose preparation staging region is disposed within the depth of field). In various embodiments, the at least one fixed optical setting may correspond to at least one of an aperture setting, a focus setting, a magnification setting, and/or other appropriate optical setting.
In another aspect, at least one light source (e.g., one or more LEDs) may be disposed in the housing. As such, the light source(s) may be operable to emit light from the housing in a direction toward the medication preparation staging region. As such, the light source may also be disposed in the enclosed volume such that the light source is also shielded from an environment external to the enclosed volume.
In still another aspect, light polarization filters may be employed in conjunction with a light source and an imaging device of the work station (e.g., to reduce glare in a medical dose preparation image captured by the imaging device). For example, the work station may include a first polarization filter disposed between the imaging device and the medication preparation staging region and a second polarization filter disposed between the light source and the medication preparation staging region. In an application, at least a portion of a transparent shield (e.g., as discussed above) may comprise at least one of the first or second polarization filters. In an embodiment the transparent shield may comprise both, the first and the second polarization filters. In an embodiment, the first polarization filter and the second polarization filter may collectively cover at least a portion of the opening of the housing. The first polarization filter and the second polarization filter may be disposed in non-overlapping relation, and the first polarization filter and the second polarization filter may have perpendicular polarization orientations. Accordingly, the polarization filters may work in conjunction to reduce glare from objects in the medication dose preparation staging region.
In an embodiment, the imaging device may be disposed in a central region of the housing opening and a peripheral region may extend about the central region. A plurality of light sources may be disposed in the peripheral region (e.g., spaced about the central region). In this regard, the first polarization filter may cover a portion of the opening corresponding to the lens of the camera and the second polarization filter may cover a portion of the opening corresponding to the light source(s).
In an embodiment, the peripheral region may extend in at least a first direction corresponding to the width of the base. The peripheral region may also extend in at least a second direction corresponding to one of the length of the base or a height of the medical dose preparation staging region extending from the base. For example, as described in greater detail below, the imaging device may be disposed in a plurality of positions relative to the medical dose preparation imaging device. Accordingly, depending upon the orientation of the imaging device, the peripheral region may extend in a direction corresponding to the length of the base and when in a second position, the peripheral region may extend in a direction corresponding to the height of the medical dose preparation staging region (e.g., extending normal to the base).
In this regard, a support member may extend between the base and the housing for supportably disposing the imaging device relative to the base (e.g., between a plurality of different positions of the imaging device relative to the base). That is, the support member may be selectively positionable in at least a first position and a second position relative to the medication preparation staging region of the base. The support member may be moveable between the first position and the second position. Additionally or alternatively, the support member may be selectively positionable in a plurality of different positions relative to the medication preparation staging region.
In an embodiment, the support member may include a first portion attached to the base and a second portion attached to the imaging device. The second portion may be moveable relative to the first portion between the first position and the second position. For instance, the first portion may be hingedly connected to the second portion. Accordingly, the first portion and the second portion may be pivotally disposable between the first position and the second position. In an embodiment, movement between the first position and the second position may be dampened.
When the support member is in the first position, the imaging field of the imaging device may extend between the imaging device and the base to encompass at least a portion of the medical dose preparation staging region. When the support member is in a second position, the imaging field may extend in a direction parallel to a support surface of the base to encompass at least a portion of the medical dose preparation staging region.
In one embodiment, the support member may extend from the base adjacent to an edge of the base extending along the width. The work station may be disposed in a laminar flow hood or the like. Accordingly, a flow of air from the laminar flow hood may be parallel to a direction corresponding to the width of the base. That is, the support may be positioned relative to the base so as not to obstruct the laminar flow of air across the base (e.g., substantially the entire base may be exposed to laminar air flow).
Furthermore, it is recognized that elimination and/or reduction of the number of wires, cables, and the like from the work station may be advantageous. For example, the reduction of wires and/or cables may provide fewer structures and surfaces that require cleaning. Furthermore, in the case where a containment structure such as a laminar airflow hood, isolator, or biological safety cabinet is used, the routing of cables to an exterior environment of the containment structure may present difficulties in maintaining an appropriate containment level of the containment structure. As such, the reduction and/or elimination of wires, cables, and the like at the work station may improve the ability to clean the work station and may assist in maintaining a level of containment of a containment structure employed at the work station.
In this regard, in an aspect, an umbilical may be provided that is at least partially disposed within a support member (e.g., to reduce the number of cables, wires, or the like in the work station). The umbilical may include at least one of a signal communication member and a power communication member. That is, the umbilical may consolidate a number of conductive members into a single cable to reduce the number of cables that need to be provided. The umbilical may be in operative communication with a processor.
In another embodiment, wireless technology may be incorporated at the work station (e.g., to completely eliminate the need for wires and the like). That is, technology may be incorporated into the work station to wirelessly communicate signals between the various components and the processor. For example, image data, lighting control data, scale information, or other communication between the devices of the work station and a processor may be facilitated by way of wireless communication. Additionally, a battery may be provided with the camera stand to facilitate wireless operation. For example, the battery may be replaceable or rechargeable to facilitate continued wireless operation.
In an application, the base of the work station may be supportably engageable with a surface with one or more suction cups. In this regard, the camera stand may be securely retained on a surface. Furthermore, the suction cups may provide some measure of vibration isolation from an exterior environment.
In another aspect, a support platform may be provided that is removably disposable relative to the base. The removal of the support platform may facilitate cleaning of the support platform. The support platform may at least partially define the medication preparation staging region. The support platform may be made of a UV resistant material to withstand discoloration or deterioration of the support platform.
In an aspect, a support surface of the support platform may define a plurality of medication receptacle engagement features. Accordingly, the support platform may include a reference plane corresponding to a surface of the support surface. In this regard, the support surface may include at least one groove defined in the support surface that may extend from the reference plane by a first depth. Additionally, the support surface may include at least one channel defined in the support surface that may extend from the reference plane by a second depth. The groove and the channel may be operable to engage a medication receptacle disposed in the medication preparation staging region. In an embodiment, the first depth may be less than the second depth.
Also, in one implementation, the groove may include a first concave surface extending from the reference plane to the first depth. The channel may comprise a second concave surface extending from the reference plane to the second depth. The first concave surface may have a first radius of curvature greater than a second radius of curvature of the second concave surface. In an embodiment, the support surface may include a plurality of grooves and/or a plurality of channels. At least one of said plurality of grooves may be disposed perpendicular to at least one of the channels. Furthermore, at least one of the plurality of grooves may extend in a first direction of the base corresponding to a width of the support surface. For example, at least one groove may extend across substantially all of the support surface in a first direction corresponding to the width of the support surface. Also, at least one of the plurality of channels may extend in a second direction of the base corresponding to the length of the support surface. For example, at least one channel may extend across substantially all of the support surface in a second direction corresponding to a length of the support surface.
Still another aspect may include a mechanism for alerting a user to the fact that a medical dose preparation image has been captured. For example, a user control device (e.g., a foot switch) may be provided that is in operative communication with the processor to initiate a capture of a medical dose preparation image from the image data obtained by the image device in response to a user input received at the user control device. In other words, the user control device may be operable to and/or adapted to receive a user input for receiving a user input to initiate capture of a medical dose preparation image from a video data stream output by the imaging device. Alternatively or additionally, other methods of triggering capture of a medical dose preparation image may be provided without limitation. In any regard, upon capture of a medical dose preparation image, an intensity of a light source may be automatically modified from a default intensity of light emitted to a modified intensity of light. In other words the light source may be operable and/or adapted such that an intensity of the at least one light source is automatically modified from a default intensity of light emitted to a modified intensity of light emitted. The change in light intensity may occur at a first predetermined period after the capture of the medical dose preparation image. Furthermore, the light source may be automatically returned from the modified intensity of light to the default intensity of light at a second predetermined period after the first predetermined period. In other words, the light source may operable to and/or adapted to be automatically returned from the modified intensity of light to the default intensity of light at a second predetermined period after the first predetermined period. The light source may be automatically returnable from the modified intensity of light to the default intensity of light. In this regard, the light source may be controlled to “blink” or “flicker” to indicate to a user that the image has been captured so that the user may proceed in the workflow.
In an embodiment, a scale may be provided that is in operative communication with the processor. The scale may be operable to output a weight corresponding to a medication receptacle that is supportably disposed in the medication preparation staging region. In this regard, the scale may be provided in corresponding relation to the base (e.g., disposed relative to the base and/or integrated with the base).
For example, the scale may be generally used to perform a gravimetric analysis of an item disposed in the medical dose preparation staging region. For example, upon capture of a medical dose preparation image, the weight of the medication receptacle may be recorded by the processor from the scale at substantially the same time that the medical dose preparation image is captured. In other words, the processor may be operable to and/or adapted to—upon receipt of a user input—record the weight from the scale at substantially the same time that the medical dose preparation image is captured. In this regard, the work station may also include a memory in operative communication with the processor for storing the weight and the medical dose preparation image. For example, the weight and the medical dose preparation image may be associatively stored in the memory. As such, the processor may be operable to compare the measured weight of the medication receptacle to an anticipated weight of the medication receptacle (e.g., provided in metadata of the order). In this regard, the processor may be operable to calculate a deviation of the measured weight to the anticipated weight. The deviation may be associatively stored in the memory with the weight, the medical dose preparation image, and/or the dose order. Furthermore, the deviation may be compared to a threshold deviation value. Accordingly, when the deviation exceeds a threshold deviation, an alert may be provided to a user. In this aspect, the base, the imaging device, and the scale may be interconnected for movement as a single unit. Moreover, the processor may be operable to and/or adapted to compare the deviation to the threshold deviation, and provide the alert to the user.
Another aspect may relate to a method comprising the steps of outputting of a video data stream of the imaging field, receiving the video data stream of the imaging field, initiating a capture of a medical dose preparation image from the video data stream in response to a user input received at a user control device, and outputting a weight corresponding to a medication receptacle that is supportably disposed in a medication preparation staging region. The method may further provide for upon receipt of the user input, recording of the weight at substantially the same time as the capture of the medical dose preparation image.
Numerous additional features and advantages of the present invention will become apparent to those skilled in the art upon consideration of the embodiment descriptions provided hereinbelow.
While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and are herein described in detail. It should be understood, however, that it is not intended to limit the invention to the particular form disclosed, but rather, the invention is to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the claims.
The medical dose orders received at the dose order input 20 may be specific to patients or may be orders that are not associated with a patient at the time of ordering. In this regard, the medical dose order may correspond to a contained medication unit that may comprise one of the following:
Examples of contained medication units that may correspond to medication dose orders include:
In the latter regard, nutritional supplements may include total parenteral nutrition (TPN) or components of TPN. Furthermore, nutritional supplements may include partial nutritional supplements. The nutritional supplements may include a pre-mix bag, base and additive components separately or in combination, or other forms of nutritional supplements or components thereof. The nutritional supplements may be for administration via intravenous injections, in an edible form, or for use with a feeding tube or the like.
In any regard, the medical dose may include one or more portions of information that may be used to assist in preparation of the mediation dose, may be associated with the administration of the dose order to a patient, or may otherwise relate to the dose order. For example, the dose order may include information corresponding to:
In any regard, the medical dose orders may be communicated to a medical dose preparation management system 30. The medical dose preparation management system 30 may be operable to acquire 50 dose order data from the dose order information received from the order processor 20. The medical dose preparation management system 30 may also preprocess 52 dose order data. The preprocessing 52 may include, for example, generating a digital dose order record that is maintained by the medical dose preparation management system 30. The digital dose order record may be automatically populated with data that may be obtained from the order such as, for example, any of the information described above in connection with the medical dose order. In this regard, information may be parsed, scraped, or otherwise obtained from the medication dose order received at the order input 20. Specifically, in an embodiment, the medical dose preparation management system 30 may be operable to scrape data addressed to a human readable output (e.g., a printer) from the order input 20 to populate the medical dose order record with data corresponding to the medical dose order.
In an embodiment, the medical dose preparation management system 30 may be in operative communication with a mediation dose order database 32. In this regard, the medication dose order database 32 may be located at the care provider facility (i.e., be on-site relative to the care provider hospital 12). The medical dose preparation management system 30 may additionally or alternatively be operable to communicate with a remote medication dose order database 34. In this regard, the medical dose preparation management system 30 may communicate with the remote medication dose order database 34 via a network or the like. In either regard, the medication dose order database 32 or 34 may be operable to store medication dose order records in the medication dose order database 32 and/or 34. In addition, the medication dose order database 32 or 34 may store dose order metadata in corresponding relation to respective ones of the stored medication dose orders. The medication dose order database 32 or 34 may store active dose orders (e.g., corresponding to dose orders that have been generated but not yet administered to the patient) or archived dose orders (e.g., corresponding to dose orders that have been administered to a patient). Redundant data may be stored at the on-site medical dose order database 32 and the off-site medical dose order database 34. For example, the off-site medical dose order database 34 may be a backup version of the on-site medical dose order database 32.
In any regard, medical dose order metadata may be stored in corresponding relation to a medication dose order. The medical dose order metadata may include, for example, the following types of data:
As may be appreciated from the foregoing description of the medical dose order metadata, a medical dose order may inherit metadata from components used in the preparation of the medical dose order. In a simple example, a medical dose order may include a first component (e.g., a drug) to be mixed with a second component (e.g., a diluent). The first component may have one or more portions of metadata as described above that are associated with the first component. Additionally, the second component may have one or more portions of metadata as described above that are associated with the second component. Thus, a medical dose order that is prepared using the first component and the second component may inherit the metadata from each of the first component and second component. In this regard, a plurality of generations of metadata may be compiled and attributed for a given medical dose order. In an embodiment, metadata for any and all components used to prepare the dose order may be compiled and attributed for a given medical dose order. As such, metadata information for the medical dose order may include metadata originating with source components provided by a manufacturer of the components of a dose order.
The medical dose preparation management system 30 may also be operative to organize 54 dose orders. The organization 54 may include prioritization, scheduling, or other tasks associated with the organization or management of dose orders. The medical dose preparation management system 30 may also be operative to route 56 dose orders to an appropriate work station 40 for use in fulfillment of the dose order. In this regard, a plurality of work stations 40 may be provided in communication with the medical dose preparation management system 30. Different ones of the plurality of work stations 40 may each be suited for different operations related to medical dose order management. As such, depending on the nature of a medical dose, a particular type of work station 40 may be used to prepare the dose. The work station 40 may be on-site relative to the care provider hospital 12 as depicted in
In any regard, the medical dose preparation management system 30 may be in operative communication with one or more work stations 40. The routing 56 of dose orders may be at least partially based on one or more factors related to the dose order or the preparation of the dose order. For example, as stated above, the nature of the contained medication unit corresponding to the dose order (e.g., whether a dose order is a chemotherapy dose order, a parenteral dose order, or other specialized dose order) may factor into a determination regarding the routing 56 of the dose order. Additionally or alternatively, the capabilities of the various work stations 40 in relation to the manner in which the dose order is to be prepared may be considered. For example, some orders may require different levels of containment, hooding, or other precautions that may or may not be provided at each work station 40. In an embodiment, other parameters such as technician schedules, work station schedules, work station location, medication dose order scheduling information, or other information may be used alone or in combination to route 56 dose orders to a particular work station 40.
At the work station 40, a work flow corresponding to the preparation of the medical dose order may be displayed 58. In this regard, a work flow that is specific to the medical dose order currently being prepared at the work station 40 may be presented to a technician at the work station 40 to assist or provide guidance to the technician preparing the dose order. Accordingly, the technician may follow a sequence of steps to prepare the medical dose based on the work flow displayed 58 that relates to the dose order.
During and/or after the preparation of the dose order, the work station 40 may be used to assist in obtaining 60 dose order metadata related to the medical dose order. For example, the work station 40 may allow for recording of documentation regarding the preparation of the medical dose such as, for example, acquiring barcode scans of products, capturing medical dose preparation images of medical dose order receptacles during or after use in the preparation of the dose, or obtaining other information related to the preparation of the dose. In an embodiment, one or more of the types of data described above in relation to the medication dose metadata may be acquired in connection with the preparation of the medical dose order at the work station 40.
At least a portion of the dose metadata obtained 60 regarding the medication dose may be stored for viewing by appropriate personnel (e.g., a pharmacist). In this regard, the dose metadata may be utilized to verify 62 the prepared dose prior to the dose being dispensed from the pharmacy 12. In an embodiment, the metadata collected at the work station 40 may be made available to a pharmacist via a network. In this regard, a pharmacist tasked with verifying 62 a dose order may access the information and/or data remotely (e.g., in a location in the hospital but outside the IV room or even entirely remove from hospital premises via the network). The ability to remotely access the metadata may allow the pharmacist to avoid having to enter the IV room to verify 62 a dose order (i.e., thus avoid the potentially burdensome gowning procedures commonly associated with entering the controlled environment of an IV room). The verifying 62 may include inspection of medical dose preparation images, obtained information, or other data regarding the medical dose order by the pharmacist. For example, the pharmacist may verify the correct medication was prepared in the correct manner and/or in the correct amounts based on metadata gathered and stored during the preparation of the medical dose order. If the medication dose order is incorrect in any regard, the pharmacist may request the medication dose order be reworked or restarted.
Once the dose order has been prepared and verified 62, the medical dose preparation management system 30 may dispense 64 the dose order. When dispensing 64 the dose order, the dose order may be dispatched from the pharmacy 12 for administration to a patient by the care provider. For example, the dose may be administered at the care provider hospital 12 or an offsite location under the direction or supervision of the care provider.
The medical dose preparation management system 30 may also facilitate tracking 66 of the dose order to administration to the patient. The pharmacy work flow manager 30 may also retain records associated with each dose that may be stored or archived. For example, the records may be stored digitally in electronically indexed and searchable form. The records may include at least a portion and preferably all metadata regarding each dose.
With further reference to
The imaging device 80 may include an imaging field 84. The imaging field 84 may encompass a medical dose preparation staging region 86. The imaging device 80 may be supportably mounted to a base 90. For example, a support 92 may extend from the base 90 to the imaging device 80 to support imaging device 80 relative to the base 80. In this regard, in an embodiment the medical dose preparation staging region 86 may include a support surface 94 of the base 90. The medical dose preparation staging region 86 may also include a volume above the surface 94 (e.g., extending from the surface in a direction normal to the surface and/or toward the imaging device 80). In any regard, the imaging field 84 of the imaging device 80 may encompass the medical dose preparation staging region 86 that may supportably receive a medication receptacle 100. In turn, the imaging device 80, support 92, and base 90 may collectively define a camera stand 200. As such, the camera stand 200 may be used at a work station 40 to support the imaging device 80 relative to the base 90 to obtain medical dose preparation image and/or other metadata during the preparation of the medical dose order.
The medication receptacle 100 supportable by the base 90 in the medical dose preparation staging region 86 may include any material, container, apparatus, or other object that is used in the preparation of a dose. For example, the medication receptacle 100 may be or include a source receptacle, a transference receptacle, or an administration receptacle. A source receptacle may store a medication product as stored in the pharmacy prior to compounding or dose preparation. In this regard, the source receptacle may be a receptacle as packaged by and received from a drug manufacturer. As such, the source receptacle may include information thereon relating to the medication. For example, the product name, concentration, amount, lot information, expiration information, a serial number, other manufacturing information or other information may be associated with the medication and/or may appear on the source receptacle. The medical dose preparation management system 30 may be operable to store metadata regarding the source receptacle including any of the foregoing portions of data that may appear on the source receptacle. In this regard, the source receptacle may be identifiable by the work station 40 (e.g., via the use of a machine readable indicium such as a bar code or the like).
Furthermore, the medical dose preparation management system 30 may be operable to attribute metadata from the source receptacle to the dose order in which the source receptacle is used as described above. The source receptacle metadata may even be attributed to or appended to the metadata for the medical dose order when the source receptacle comprises a pre-prepared medication that has been compounded at the pharmacy and disposed in the source receptacle for later use in the preparation of a dose. In this regard, the metadata for several generations of components used to prepare a medical dose order (e.g., originating from original source components received from a manufacturer such as a drug manufacturer) may be attributed to the medical dose order. As such, the medical dose order metadata may include information regarding all components used in the medical dose order including inherited metadata. The metadata for the various components may be retrieved upon identification of the receptacle 100 at the work station 40 (e.g., by way of scanning a machine readable indicium). In various embodiments, the source receptacle may include a vial, a syringe, a bottle, a bag, or other appropriate medication receptacle known in the art.
An administration receptacle may be any receptacle used during the administration of the medical dose to the patient. The administration receptacle may contain any medication, diluent, supplement, or any other material to be administered to the patient. In various embodiments, the administration receptacle may include a syringe, an IV bag, or other appropriate medication receptacle used in the administration of a substance to patient. An administration receptacle may also include metadata that is included in the metadata for the prepared medical dose order.
The transference receptacle may be used to transfer a substance from a source receptacle to the administration receptacle. For example, the transference receptacle may be a syringe or any other appropriate receptacle known in the art capable of transferring a substance from the source receptacle to the administration receptacle. A transference receptacle may also include metadata that is included in the metadata for the prepared medical dose order.
Returning to
Medical dose preparation images captured by the video data stream processing module 72 may include one or more medication receptacles 100 used in the course of preparing a medical dose order. In this regard, the preparation of medical dose orders may be documented by capturing images of the medication receptacles 100 used to prepare the dose. The medical dose preparation images may be stored as metadata regarding the medical dose order. A medical dose preparation image may include one or more medication receptacles at various stages during the preparation of the dose. For example, a source receptacle, a transference receptacle, or an administration receptacle may be imaged before, during or after preparation of the dose.
The medical dose preparation images captured by the video data stream processing module 72 may be stored in a memory 120 in operative communication with the processor 70. In this regard, the medical dose preparation images may be stored locally in the memory 120 at the work station 40. Additionally or alternatively, the medical dose preparation images may be communicated to a remote location (e.g., an on-site medication dose order database 32 or an off-site medication dose order database 34 shown in
The processor 70 may also be in operative communication with a user control device 130. The user control device 130 may be operable to receive an input from a user (e.g., a pharmacy technician preparing a dose). The user control device 130 may be, for example, a foot pedal, a button, a touch screen, a mouse, a keyboard, or other user input device known in the art. A user may utilize the user control device 130 to trigger the capture of a medical dose preparation image from the video data stream 82. For example, a medication receptacle 100 may be viewed by the user by observing the display 110 displaying the video data stream 82 captured by the imaging device 80 of imaging field 86 including the medication receptacle 100. Once the image displayed on the display 110 is acceptable to the user, the user may use the user control device 130 to trigger the capture of the medical dose preparation image for storage in the memory 120 or in a remote database as described above.
The work station 40 may also include a printer 150 that is operative to print dose labels associated with a medical product, a dose that is in progress, and/or a completed dose. In this regard, the printer 150 may be a label printer operative to print labels used in the pharmacy 12 and/or hospital in connection with metal doses and/or medical dose orders.
With further reference to
The transparent shield 216 may extend across at least a portion of the opening 214 (e.g., in corresponding relation to the lens 226). In an embodiment, the transparent shield 216 may extend across substantially the entire opening 214. In this regard, the housing 210 and the transparent shield 216 may collectively define an enclosed volume 218 (best seen in
Also disposed within the enclosed volume 218 may be a light source board 228. The light source board 228 may include one or more light sources 230 connected to the light source board 228. The light sources 230 may comprise individual light emitting diodes (LED). The light sources 230 may be attached to the light source board 228 such that power and/or control signals used in the operation of the light sources 230 are provided to the light sources 230 by way of the light source board 228. In this regard, the light source board 228 may provide a physical mounting substrate for supportably engaging the light sources 230 as well as providing electrical communication between the light sources 230 and the light source board 228. In this regard, the light source board 228 may be a printed circuit board (PCB) including attachment locations and appropriate electrical communication paths (e.g., conductive traces) to facilitate attachment and electrical communication between the light sources 230 and the light source board 228.
The light source board 228 may include an aperture 232. A lens 226 of the camera 212 may be aligned with the aperture 232 such that an imaging field 84 of the camera 212 defined by the lens 226 extends through the aperture 232. The aperture 232 may also be aligned with a central region of the opening 214 of the housing 210. As such, a peripheral region extending about the central region of the opening 214 may be occupied by the light source board 228, and thus the light sources 230. In this regard, the light sources 230 may be provided peripherally about the aperture 232 of the light source board 228, and thus the lens 226 of the camera 212. The light sources 230 may emit light through the opening 214. As such, the light emitted from the light sources 230 may at least partially coincide with the imaging field 84 of the camera 212. In this regard, the distribution of the light sources 230 as shown in
With further reference to
As can further be appreciated in
In this regard, the peripheral polarization filter 222 and the central polarization filter 224 may be disposed such that the direction of polarization of the filters are oriented perpendicularly to each other.
Accordingly, as light is emitted from the light sources 230, the emitted light may pass through the peripheral polarization filter 222 and, thus, be polarized according to the first direction of polarization associated with the peripheral polarization filter 222. The light may then travel toward the medical dose preparation staging region 86, which may become illuminated by the emitted light polarized in the first direction. The emitted light originating from the light sources 230 may be reflected from the medical dose preparation staging region 86. In turn, the emitted light may then pass through the central polarization filter 224, where the reflected light is then polarized in a second direction of polarization by the central polarization filter 224 that is perpendicular to the first direction of polarization associated with the polarization filter 222. In this regard, light emitted from the housing 210 may be polarized in the first direction of polarization by the peripheral polarization filter 222, be reflected back from the medical dose preparation region 86 such that the polarization of at least some of the light is changed, and be polarized in the second direction of polarization by the central polarization filter 224. The result may be reduced glare on objects placed in the medical dose preparation staging region 86. For example, especially in the case of shiny materials such as glass, light that impinges on an object in the medical dose preparation staging region 86 normal to the surface may not undergo a change in polarization. Thus, the light incident normal to the object that may result in glare does not change in polarization from the first direction. The introduction of the central polarization filter 224 with a polarization in the second direction may fully block the reflected light that is still in the first polarization direction because the light was reflected normal to the surface, thus reducing the glare the light in the first polarization direction may otherwise produce.
To achieve the foregoing relative orientations of the polarization of the peripheral polarization filter 222 and the central polarization filter 224, the respective filters may be manufactured from a unitary sheet of polarized material. With respect to
Additionally or alternatively, other optical filters may be provided other than the polarization filters described above. For example, a diffusion filter may be provided that may provide more uniform light distribution at the medical dose preparation staging region 86. Other optical filters such as high pass, low pass, band pass, or any other appropriate optical filters may be employed to selectively control the emission of light from the light source. Additionally, light sources that emit certain wave length light may also be employed. Further still, light sources may be employed that are operable to controllably emit different wave length light (e.g., the color of the light may be controlled).
It may be appreciated in
Accordingly, in an embodiment, the camera 212 includes at least one fixed optical setting. For example, one or more optical settings may be fixed such that a depth of field of the camera 212 as defined by the lens 226 encompasses at least a portion of the medical dose preparation staging region 86. In an embodiment, at least a majority of the medical dose preparation staging region 86 is encompassed by a depth of field of the camera 212. In an embodiment, substantially all of the medical dose preparation staging region 86 is encompassed by a depth of field of the camera 212. The fixed optical settings of the camera 212 may comprise a focus setting, an aperture setting, a magnification, or another optical setting affecting the depth of field of the camera 212.
In another embodiment, the optical settings of the camera 212 may be adjustable (e.g., by a user). For example, a focal length, magnification, or other optical parameter of the camera 212 may be adjusted. The adjustment of the optical settings may be manually accomplished by a user manipulating a portion of the camera 212. In an application, an electronic signal may be provided to the camera 212 in order to adjust the optical settings thereof. In an embodiment, camera 212 may be continuously adjustable through a continuum of settings associated with one or more optical parameters. In another embodiment, a plurality of discrete optical parameters may be selectable. For example, the optical parameters the camera 212 may be selected from among at least two different optical parameter settings. For example, a corresponding optical parameter setting may be selected based on a selected position of the camera 212 relative to the base 90. In this regard, the camera 212 may be disposed at different distances relative to the base for different positions of the support 92 and/or for different configurations of the camera stand 200. In this regard, for the various different configurations available, discrete optical setting may be provided for each position of the imaging device 80 relative to the base 90 such that the optical parameters associated with the camera 212 results in a clear image of the medication receptacle 100 being imaged by the camera 212.
In an embodiment, the light sources 230 may be used to indicate when a medical dose preparation image has been captured. That is, as described above, a user control device 130 may be used to initiate the capture of a medical dose preparation image from a video data stream 82. In a first predetermined period after the capture of the medical dose preparation image, the intensity of at least one of the light sources 230 may be changed. The change in intensity may indicate to the user that the image has successfully been captured. In this regard, the light intensity of the light source 230 may change from a default level to a modified intensity (e.g., either more or less intense). The light source 230 may then return to the default intensity after a second predetermined period of time. In this regard, the light source 230 may “blink” or “flicker” or momentarily change from the default intensity to a modified intensity and then return to the default intensity). The variation in intensity may be readily perceived by a user to indicate the image has been captured and that the medical dose preparation staging region 86 may be cleared and, for example, prepared for the next image.
Returning to
In this regard, the support arm 92 may include a first portion 234 and a second portion 236. The first portion 234 may be supportably engaged with the housing 210 and the second portion 236 may be supportably engaged with the base 90. The first portion 234 may be positionably attached to the second portion 236 at a connection 238. For example, the first portion 234 may be moveably attached to the second portion 236 such that the first portion 234 may undergo relative movement with respect to the second portion 236 to move between the first position depicted in
The movement of the first portion 234 relative to the second portion 236 may be dampened and/or dampenable. In this regard, connection 238 may include a dampener that dampens movement of the first portion 234 relative to the second portion 236. In one embodiment, the dampener may comprise coordinating elliptical profiles provided on each of the first portion 234 and the second portion 236 at the connection 238. The elliptical profiles may be provided as coordinating surfaces of the first portion 234 and the second portion 236. Other shaped profiles may be provided other than elliptical profiles such as, for example, a non-uniform contoured shape (e.g., profile defining one or more cam lobes).
One embodiment illustrating the use of coordinating elliptical surfaces to achieve dampened movement between the first portion 234 and the second portion 236 is shown in
As may be appreciated in
In the second position (shown in
The support 92 may also contain at least a portion of an umbilical 268 that may be operable to establish communication between the components disposed in the enclosed volume 218 (e.g., the camera 212, the light source board 228, light sources 230, etc.). In this regard, the umbilical 268 may establish electrical communication paths between the components in the enclosed volume 218 and the processor 70. In some embodiments, the umbilical 268 may include one or more bundled or consolidated cables, one or more conductive traces, a plurality of wires, or other appropriate conductors to establish electrical communication between the components in the enclosed volume 218 and the processor 70. As shown in
It may be noted that the umbilical 268 may provide electrical communication paths for a plurality functions. For example, signal paths and/or power communication paths may be provided in the umbilical 268. In this regard, plurality of discrete electrical communication paths may be consolidated into a single cord extending from the camera support 200. In the context of a work station 40, the minimization of wires in the work area may provide advantages, especially in the context of cleaning the workstation 40. That is, the fewer wires present in a work area (such as a laminar flow hood, isolator, or biological safety cabinet) the easier the work station 40 may be to clean.
Furthermore, in the context of, for example, a biological safety cabinet, it may be appreciated that elimination of wires or cables extending from the camera stand altogether may be particularly advantageous. For example, a biological safety cabinet may provide complete isolation from an external environment. In this regard, should a camera stand 200 include a cord, the cord may be required to pass through the wall of the biological safety cabinet. However, a minimum level of containment must also be maintained, which may be difficult or costly to achieve while facilitating passage of the cord through the cabinet wall. In this regard, it is contemplated that the camera stand 200 may be completely wireless. For example, wireless technology may be incorporated to the camera stand 200 to facilitate communication of electronic signals between the camera stand 200 and the processor 70. Examples of such wireless technology include Wi-Fi, Bluetooth, or other wireless vacation technologies. Furthermore, the camera stand 200 may be equipped with a battery to provide operational power to the camera stand 200. The battery may be removable, replaceable, and/or rechargeable to facilitate wireless operation of the camera stand 200. For example, a lithium-ion battery or other appropriate type of battery may be provided in the camera stand 200. The battery and provided any portion of the camera stand 200 without limitation including for example, the base 90, the support 92, and/or the enclosed volume 218.
With further reference to
Accordingly, as depicted in
In this regard, it may be appreciated that once the attachment member 304 is secured to the first portion 234, the mounting plate 300 is secured to the attachment member 304, the mounting structure 310 is secured to the mounting plate 300, and the camera 212 secured to the mounting structure 310, the alignment of the camera 212 may be non-perpendicular to the base 90 (i.e., the imaging tolerance may not be achieved). In this regard, the jack nuts 322 may be manipulated so as to align the camera 212 to be substantially perpendicular to the base 90 such that any image distortion such as keystoning may be eliminated from the resultant image obtained by camera 212. In other words, the imaging tolerance may be achieved via adjustment of the gimbal 320. As such, the amount of adjustment provided by the gimbal 320 may at least correspond to the difference between the connection tolerance and the imaging tolerance associated with the alignment of the camera 212 to the base 90.
It may be appreciated that the mounting plate 300 and/or mounting structure 310 may be fabricated from sheet material. In this regard, the manufacturer of these components may be provided at significant lower cost than other manufacturing techniques that may be employed when tolerances are required to be relatively high. In this regard, the use of the gimbal 320 provide adjustability of the alignment of the camera 212 once secured to a mounting structure may allow for manufacturing techniques that are less costly to be employed when manufacturing the camera stand 200.
While not shown in
With further reference to
The support platform 256 may have a length 272 and a width 274. In this regard, when the support platform 256 is disposed on the platform base 254, the length 272 and width 274 may define dimensions of the base 90. The length 272 and the width 274 may also correspond to a medical preparation staging region 86 at least partially defined by the support platform 256.
Additionally, with reference to
The platform base 254 may include a scale such that an item disposed on the support platform 256 when disposed on the platform base 254 may be weighed. For example, the weight measured by the scale may be captured substantially simultaneously as the capture of a medical dose preparation image by the imaging device 80. Accordingly, the weight obtained by the scale may be appended to the dose order metadata. In an embodiment, the processor 70 at the processor or a remote processor with access to the metadata may perform a gravimetric analysis using a weight measured by the scale to, for example, compare the measured weight to an anticipated weight for the medical dose. The scale may comprise load cells disposed in the platform base 254 (e.g., at each foot 258 of the platform base 258 or adjacent to where the support platform 256 is supported.
In this regard, the anticipated weight for the medical dose may be contained in the metadata to assist in a gravimetric analysis of the medication receptacle 100. The processor 70 at the work station 40 may associatively store the anticipated weight and the measured weight. Furthermore, the processor may be operable to compare the measured weigh to the anticipated weight. In an embodiment, a deviation of the actual weight from the anticipated weight may be calculated and if the deviation exceeds a threshold, an alarm may be provided to the user.
The support platform 256 may at least partially define the medication preparation staging region 86. For example, the medication preparation staging region 86 may encompass a volume extending in a direction normal to a support surface 262 of the support platform 254. As such, a receptacle supportably engaged by the support platform 254 may be encompassed by the medication preparation staging region 86 such that the receptacle is disposed in the imaging field of the imaging device 80.
The support platform 254 may also include one of more medication receptacle engagement feature that may engage a medical receptacle that is supportably disposed with respect to the support platform 254. For example, the medication receptacle engagement features may include at least one groove 264 and at least one channel 266. With further reference to
The grooves 264 may have a first radius of curvature in a direction corresponding to the first depth from which the grooves 264 extend from the support surface 262. In this regard, the grooves 264 may have a generally concave profile. For example, a concave surface profile may be defined along the groove 264. Similarly the channel 266 may include a second radius of curvature in a direction corresponding with the second depth. In this regard, the channels 266 may also have a generally concave profile (e.g., a concave surface profile). The first radius of curvature may be larger than the second radius of curvature such that the grooves 264 include a shallower profile versus a steeper profile of the channels 266.
In an embodiment, the grooves 264 may be adapted to engage a first portion of a medication receptacle. For example, the concave surface profile of the grooves 264 may correspond with the circumference of the barrel of a syringe. In this regard, the syringe barrel may be received in the grooves 264 such that movement of the syringe barrel corresponding to rolling of the syringe may be restricted when disposed on the support platform 256 and engaged by a groove 264. In a similar regard, the channels 266 may be adapted to engage a second portion of a medication receptacle. For example, the concave surface profile of the channels 266 may correspond with finger rest of a syringe. Additionally or alternatively, the concave surface profile of the channels 266 may correspond with a plunger end. In this regard, when the barrel of a syringe is disposed in a groove 264, the finger rest and/or plunger end of the syringe may be engaged by the channel 266 that may restrict motion of the syringe along the length of the groove 264. As such, the syringe may be constrained in at least two degrees of freedom to reduce the potential the syringe mistakenly moves (e.g., slides, is disrupted, or otherwise moved) from the support platform 256. It may also be appreciated that the concave surface profile of the grooves 264 and/or the channels 266 may be operable to retain a cylindrical body (e.g., a vial, bottle, or other cylindrical container) to prevent rolling movement thereof.
The foregoing description of the present invention has been presented for purposes of illustration and description. Furthermore, the description is not intended to limit the invention to the form disclosed herein. Consequently, variations and modifications commensurate with the above teachings, and skill and knowledge of the relevant art, are within the scope of the present invention. The embodiments described hereinabove are further intended to explain known modes of practicing the invention and to enable others skilled in the art to utilize the invention in such or other embodiments and with various modifications required by the particular application(s) or use(s) of the present invention. It is intended that the appended claims be construed to include alternative embodiments to the extent permitted by the prior art.
This application is a continuation of U.S. patent application Ser. No. 15/193,494, having a filing date of Jun. 27, 2016, entitled “WORK STATION FOR MEDICAL DOSE PREPARATION SYSTEM”, which is a continuation of U.S. patent application Ser. No. 14/438,559, now U.S. Pat. No. 9,375,079, having a 371(c) filing date of Apr. 24, 2015, entitled “WORK STATION FOR MEDICAL DOSE PREPARATION SYSTEM,” which is a U.S. National Stage of International Patent Application No. PCT/US2013/032545, filed Mar. 15, 2013, entitled “IMPROVED WORK STATION FOR MEDICAL DOSE PREPARATION SYSTEM,” which claims the benefit of and priority to U.S. Provisional Patent Application No. 61/719,256 filed Oct. 26, 2012, entitled “WORK STATION FOR MEDICAL DOSE PREPARATION SYSTEM,” all of which foregoing patent applications are incorporated herein by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 641748 | Smith | Jan 1900 | A |
| 819339 | Cleland | May 1906 | A |
| 3426150 | Tygart | Feb 1969 | A |
| 3739943 | Williamsen et al. | Jun 1973 | A |
| 3742938 | Stern | Jul 1973 | A |
| 3756752 | Stenner | Sep 1973 | A |
| 3774762 | Lichtenstein | Nov 1973 | A |
| 3786190 | Pori | Jan 1974 | A |
| 3809871 | Howard et al. | May 1974 | A |
| 3810102 | Parks, III et al. | May 1974 | A |
| 3848112 | Weichselbaum et al. | Nov 1974 | A |
| 3858574 | Page | Jan 1975 | A |
| 3878967 | Joslin et al. | Apr 1975 | A |
| 3910257 | Fletcher et al. | Oct 1975 | A |
| 3910260 | Sarnoff et al. | Nov 1975 | A |
| 3921196 | Patterson | Nov 1975 | A |
| 3971000 | Cromwell | Jul 1976 | A |
| 3995630 | Verrdonk | Dec 1976 | A |
| 3998103 | Bjorklund et al. | Dec 1976 | A |
| 4032908 | Rice et al. | Jun 1977 | A |
| 4078562 | Friedman | Mar 1978 | A |
| 4144496 | Cunningham et al. | Mar 1979 | A |
| 4151407 | McBride et al. | Apr 1979 | A |
| 4156867 | Bench et al. | May 1979 | A |
| 4164320 | Irazoqui et al. | Aug 1979 | A |
| 4173971 | Karz | Nov 1979 | A |
| 4199307 | Jassawalla | Apr 1980 | A |
| 4270532 | Franetzki et al. | Jun 1981 | A |
| 4273121 | Jassawalla | Jun 1981 | A |
| 4282872 | Franetzki et al. | Aug 1981 | A |
| 4308866 | Jelliffe et al. | Jan 1982 | A |
| 4319338 | Grudowski et al. | Mar 1982 | A |
| 4320757 | Whitney et al. | Mar 1982 | A |
| 4354252 | Lamb et al. | Oct 1982 | A |
| 4369780 | Sakai | Jan 1983 | A |
| 4370983 | Lichtenstein | Feb 1983 | A |
| 4373527 | Fischell | Feb 1983 | A |
| 4381776 | Latham, Jr. | May 1983 | A |
| 4385630 | Gilcher et al. | May 1983 | A |
| 4398289 | Schoate | Aug 1983 | A |
| 4398908 | Siposs | Aug 1983 | A |
| 4414566 | Peyton et al. | Nov 1983 | A |
| 4416654 | Schoendorfer et al. | Nov 1983 | A |
| 4425114 | Schoendorfer et al. | Jan 1984 | A |
| 4428381 | Hepp | Jan 1984 | A |
| 4443216 | Chappell | Apr 1984 | A |
| 4447224 | DeCant, Jr. et al. | May 1984 | A |
| 4449538 | Corbitt et al. | May 1984 | A |
| 4451255 | Bujan et al. | May 1984 | A |
| 4457750 | Hill | Jul 1984 | A |
| 4458693 | Badzinski et al. | Jul 1984 | A |
| 4460358 | Somerville et al. | Jul 1984 | A |
| 4464172 | Lichtenstein | Aug 1984 | A |
| 4469481 | Kobayashi | Sep 1984 | A |
| 4475901 | Kraegen et al. | Oct 1984 | A |
| 4476381 | Rubin | Oct 1984 | A |
| 4480751 | Lueptow | Nov 1984 | A |
| 4481670 | Freeburg | Nov 1984 | A |
| 4487604 | Iwatschenko et al. | Dec 1984 | A |
| 4490798 | Franks et al. | Dec 1984 | A |
| 4496351 | Hillel et al. | Jan 1985 | A |
| 4511352 | Theeuwes et al. | Apr 1985 | A |
| 4525861 | Freeburg | Jun 1985 | A |
| 4526574 | Pekkarinen | Jul 1985 | A |
| 4529401 | Leslie et al. | Jul 1985 | A |
| 4531527 | Reinhold, Jr. et al. | Jul 1985 | A |
| 4538138 | Harvey et al. | Aug 1985 | A |
| 4545071 | Freeburg | Oct 1985 | A |
| 4551133 | Zegers de Beyl et al. | Nov 1985 | A |
| 4559038 | Berg et al. | Dec 1985 | A |
| 4560979 | Rosskopf | Dec 1985 | A |
| 4561443 | Hogrefe et al. | Dec 1985 | A |
| 4562751 | Nason | Jan 1986 | A |
| 4564054 | Gustaysson | Jan 1986 | A |
| 4590473 | Burke et al. | May 1986 | A |
| 4602249 | Abbott | Jul 1986 | A |
| 4619653 | Fischell | Oct 1986 | A |
| 4622979 | Katchis et al. | Nov 1986 | A |
| 4624661 | Arimond | Nov 1986 | A |
| 4636950 | Caswell et al. | Jan 1987 | A |
| 4637817 | Archibald et al. | Jan 1987 | A |
| 4650469 | Berg et al. | Mar 1987 | A |
| 4652262 | Veracchi | Mar 1987 | A |
| 4653010 | Figler et al. | Mar 1987 | A |
| 4676776 | Howson | Jun 1987 | A |
| 4681563 | Deckert et al. | Jul 1987 | A |
| 4688167 | Agarwal | Aug 1987 | A |
| 4691580 | Fosslien | Sep 1987 | A |
| 4695954 | Rose et al. | Sep 1987 | A |
| 4696671 | Epstein et al. | Sep 1987 | A |
| 4697928 | Csongor | Oct 1987 | A |
| 4702595 | Mutschler et al. | Oct 1987 | A |
| 4705506 | Archibald | Nov 1987 | A |
| D293135 | Medema et al. | Dec 1987 | S |
| 4714462 | DiComenico | Dec 1987 | A |
| 4717042 | McLaughlin | Jan 1988 | A |
| 4718576 | Tamura et al. | Jan 1988 | A |
| 4722224 | Scheller et al. | Feb 1988 | A |
| 4722349 | Baumberg | Feb 1988 | A |
| 4722734 | Kolln | Feb 1988 | A |
| 4730849 | Siegel | Mar 1988 | A |
| 4731058 | Doan | Mar 1988 | A |
| 4732411 | Siegel | Mar 1988 | A |
| 4741732 | Crankshaw et al. | May 1988 | A |
| 4741736 | Brown | May 1988 | A |
| 4756706 | Kerns et al. | Jul 1988 | A |
| 4759756 | Forman | Jul 1988 | A |
| 4770184 | Greene et al. | Sep 1988 | A |
| 4778449 | Weber et al. | Oct 1988 | A |
| 4779626 | Peel et al. | Oct 1988 | A |
| 4784645 | Fischell | Nov 1988 | A |
| 4785799 | Schoon et al. | Nov 1988 | A |
| 4785969 | McLaughlin | Nov 1988 | A |
| 4796644 | Polaschegg | Jan 1989 | A |
| 4797840 | Fraden | Jan 1989 | A |
| 4803625 | Fu et al. | Feb 1989 | A |
| 4810090 | Boucher | Mar 1989 | A |
| 4810243 | Howson | Mar 1989 | A |
| 4811844 | Moulding, Jr. et al. | Mar 1989 | A |
| 4816208 | Woods et al. | Mar 1989 | A |
| 4817044 | Ogren | Mar 1989 | A |
| 4828545 | Epstein et al. | May 1989 | A |
| 4829524 | Yoshida | May 1989 | A |
| 4830018 | Treach | May 1989 | A |
| 4831562 | McIntosh et al. | May 1989 | A |
| 4832033 | Maher et al. | May 1989 | A |
| 4835372 | Gombrich et al. | May 1989 | A |
| 4835521 | Andrejasich et al. | May 1989 | A |
| 4838275 | Lee | Jun 1989 | A |
| 4839806 | Goldfischer et al. | Jun 1989 | A |
| 4845644 | Anthias et al. | Jul 1989 | A |
| 4847764 | Halvorson | Jul 1989 | A |
| 4850009 | Zook et al. | Jul 1989 | A |
| 4850972 | Schulman et al. | Jul 1989 | A |
| 4853521 | Claeys et al. | Aug 1989 | A |
| 4854324 | Hirschman et al. | Aug 1989 | A |
| 4857713 | Brown | Aug 1989 | A |
| 4857716 | Gombrich et al. | Aug 1989 | A |
| 4865584 | Epstein et al. | Sep 1989 | A |
| 4871351 | Feingold | Oct 1989 | A |
| 4878175 | Norden-Paul et al. | Oct 1989 | A |
| 4880013 | Chio | Nov 1989 | A |
| 4889132 | Hutcheson et al. | Dec 1989 | A |
| 4889134 | Greenwold et al. | Dec 1989 | A |
| 4893270 | Beck et al. | Jan 1990 | A |
| 4897777 | Janke et al. | Jan 1990 | A |
| 4898209 | Zbed | Feb 1990 | A |
| 4898576 | Philip | Feb 1990 | A |
| 4898578 | Rubalcaba, Jr. | Feb 1990 | A |
| 4901728 | Hutchison | Feb 1990 | A |
| 4905163 | Garber et al. | Feb 1990 | A |
| 4908017 | Howson et al. | Mar 1990 | A |
| 4912623 | Rantala et al. | Mar 1990 | A |
| 4916441 | Gombrich et al. | Apr 1990 | A |
| 4922922 | Pollock et al. | May 1990 | A |
| 4925444 | Orkin et al. | May 1990 | A |
| 4933843 | Scheller et al. | Jun 1990 | A |
| 4937777 | Flood et al. | Jun 1990 | A |
| 4941808 | Qureshi et al. | Jul 1990 | A |
| 4943279 | Samiotes et al. | Jul 1990 | A |
| 4943987 | Asahina et al. | Jul 1990 | A |
| 4946445 | Lynn | Aug 1990 | A |
| 4949274 | Hollander et al. | Aug 1990 | A |
| 4952928 | Carroll et al. | Aug 1990 | A |
| 4953074 | Kametani et al. | Aug 1990 | A |
| 4960230 | Marelli | Oct 1990 | A |
| 4964847 | Prince | Oct 1990 | A |
| 4966579 | Polaschegg | Oct 1990 | A |
| 4967928 | Carter | Nov 1990 | A |
| 4968295 | Neumann | Nov 1990 | A |
| 4975647 | Downer et al. | Dec 1990 | A |
| 4977590 | Milovancevic | Dec 1990 | A |
| 4978335 | Arthur, III | Dec 1990 | A |
| 4991091 | Allen | Feb 1991 | A |
| 4992926 | Janke et al. | Feb 1991 | A |
| 4993068 | Piosenka et al. | Feb 1991 | A |
| 4993506 | Angel | Feb 1991 | A |
| 4998249 | Bennett et al. | Mar 1991 | A |
| 5002055 | Merki et al. | Mar 1991 | A |
| 5003296 | Lee | Mar 1991 | A |
| 5006699 | Felkner et al. | Apr 1991 | A |
| 5007429 | Treatch et al. | Apr 1991 | A |
| 5012402 | Akiyama | Apr 1991 | A |
| 5012411 | Policastro et al. | Apr 1991 | A |
| 5014875 | McLaughlin et al. | May 1991 | A |
| 5016172 | Dessertine | May 1991 | A |
| 5023770 | Siverling | Jun 1991 | A |
| 5025374 | Roizen et al. | Jun 1991 | A |
| 5036852 | Leishman | Aug 1991 | A |
| 5038800 | Oba | Aug 1991 | A |
| 5041086 | Koenig et al. | Aug 1991 | A |
| 5045048 | Kaleskas et al. | Sep 1991 | A |
| 5047959 | Phillips et al. | Sep 1991 | A |
| 5053031 | Borsanyi | Oct 1991 | A |
| 5053990 | Kreifels et al. | Oct 1991 | A |
| 5055001 | Natwick et al. | Oct 1991 | A |
| 5057076 | Polaschegg | Oct 1991 | A |
| 5061243 | Winchell et al. | Oct 1991 | A |
| 5072356 | Watt et al. | Dec 1991 | A |
| 5072383 | Brimm et al. | Dec 1991 | A |
| 5072412 | Henderson, Jr. et al. | Dec 1991 | A |
| 5078683 | Sancoff et al. | Jan 1992 | A |
| 5084828 | Kaufman et al. | Jan 1992 | A |
| 5087245 | Doan | Feb 1992 | A |
| 5088904 | Okada | Feb 1992 | A |
| 5088981 | Howson et al. | Feb 1992 | A |
| 5088990 | Hivale et al. | Feb 1992 | A |
| 5096385 | Georgi et al. | Mar 1992 | A |
| 5098377 | Borsanyi et al. | Mar 1992 | A |
| 5100380 | Epstein et al. | Mar 1992 | A |
| 5100394 | Dudar et al. | Mar 1992 | A |
| 5103211 | Daoud et al. | Apr 1992 | A |
| 5104374 | Bishko et al. | Apr 1992 | A |
| 5108131 | Nassim | Apr 1992 | A |
| 5108363 | Tuttle et al. | Apr 1992 | A |
| 5108367 | Epstein et al. | Apr 1992 | A |
| 5108372 | Swenson | Apr 1992 | A |
| 5109487 | Ohgomori et al. | Apr 1992 | A |
| 5109849 | Goodman et al. | May 1992 | A |
| 5112319 | Lai | May 1992 | A |
| 5116203 | Natwick et al. | May 1992 | A |
| 5116312 | Blankenship et al. | May 1992 | A |
| 5131092 | Sackmann et al. | Jul 1992 | A |
| 5134574 | Beaverstock et al. | Jul 1992 | A |
| 5135500 | Zdeb | Aug 1992 | A |
| 5137023 | Mendelson et al. | Aug 1992 | A |
| 5151978 | Bronikowski et al. | Sep 1992 | A |
| 5152296 | Simons | Oct 1992 | A |
| 5153416 | Neeley | Oct 1992 | A |
| 5153827 | Coutre et al. | Oct 1992 | A |
| 5155693 | Altmayer et al. | Oct 1992 | A |
| 5157595 | Lovrenich | Oct 1992 | A |
| 5158091 | Butterfield et al. | Oct 1992 | A |
| 5159673 | Sackmann et al. | Oct 1992 | A |
| 5160320 | Yum et al. | Nov 1992 | A |
| 5161211 | Taguchi et al. | Nov 1992 | A |
| 5167235 | Seacord et al. | Dec 1992 | A |
| 5169642 | Brinker et al. | Dec 1992 | A |
| 5172698 | Stanko | Dec 1992 | A |
| 5176004 | Gaudet | Jan 1993 | A |
| 5179569 | Sawyer | Jan 1993 | A |
| 5179700 | Aihara et al. | Jan 1993 | A |
| 5181910 | Scanlon | Jan 1993 | A |
| 5190185 | Blechl | Mar 1993 | A |
| 5190522 | Wojcicki et al. | Mar 1993 | A |
| 5191891 | Righter | Mar 1993 | A |
| 5208762 | Charhut et al. | May 1993 | A |
| 5208907 | Shelton et al. | May 1993 | A |
| 5211849 | Kitaevich et al. | May 1993 | A |
| 5213099 | Tripp, Jr. | May 1993 | A |
| 5213232 | Kraft et al. | May 1993 | A |
| 5213568 | Lattin et al. | May 1993 | A |
| 5219330 | Bollish et al. | Jun 1993 | A |
| 5219331 | Vanderveen | Jun 1993 | A |
| 5225974 | Mathews et al. | Jul 1993 | A |
| 5226425 | Righter | Jul 1993 | A |
| 5228450 | Sellers | Jul 1993 | A |
| 5231990 | Gauglitz | Aug 1993 | A |
| 5234404 | Tuttle et al. | Aug 1993 | A |
| 5235510 | Yamada et al. | Aug 1993 | A |
| 5236416 | McDaniel et al. | Aug 1993 | A |
| 5238001 | Gallant et al. | Aug 1993 | A |
| 5240007 | Pytel et al. | Aug 1993 | A |
| 5244463 | Cordner, Jr. et al. | Sep 1993 | A |
| 5245704 | Weber et al. | Sep 1993 | A |
| 5254096 | Rondelet et al. | Oct 1993 | A |
| 5256156 | Kern et al. | Oct 1993 | A |
| 5256157 | Samiotes et al. | Oct 1993 | A |
| 5261884 | Stern et al. | Nov 1993 | A |
| 5262943 | Thibado et al. | Nov 1993 | A |
| 5265010 | Evans-Paganelli et al. | Nov 1993 | A |
| 5265431 | Gaudet et al. | Nov 1993 | A |
| 5267174 | Kaufman et al. | Nov 1993 | A |
| 5271405 | Boyer et al. | Dec 1993 | A |
| 5272318 | Gorman | Dec 1993 | A |
| 5272321 | Otsuka et al. | Dec 1993 | A |
| 5273517 | Barone et al. | Dec 1993 | A |
| 5277188 | Selker | Jan 1994 | A |
| 5283861 | Dangler et al. | Feb 1994 | A |
| 5284150 | Butterfield et al. | Feb 1994 | A |
| 5286252 | Tuttle et al. | Feb 1994 | A |
| 5292029 | Pearson | Mar 1994 | A |
| 5297257 | Struger et al. | Mar 1994 | A |
| 5298021 | Sherer | Mar 1994 | A |
| 5304126 | Epstein et al. | Apr 1994 | A |
| 5307263 | Brown | Apr 1994 | A |
| 5307372 | Sawyer et al. | Apr 1994 | A |
| 5307463 | Hyatt et al. | Apr 1994 | A |
| 5311908 | Barone et al. | May 1994 | A |
| 5314243 | McDonald et al. | May 1994 | A |
| 5315505 | Pratt et al. | May 1994 | A |
| 5317506 | Coutre et al. | May 1994 | A |
| 5319363 | Welch et al. | Jun 1994 | A |
| 5319543 | Wilhelm | Jun 1994 | A |
| 5321618 | Gessman | Jun 1994 | A |
| 5321829 | Zifferer | Jun 1994 | A |
| 5324422 | Colleran et al. | Jun 1994 | A |
| 5325478 | Shelton et al. | Jun 1994 | A |
| 5327341 | Whalen et al. | Jul 1994 | A |
| 5331549 | Crawford, Jr. | Jul 1994 | A |
| 5336245 | Adams et al. | Aug 1994 | A |
| 5337230 | Baumgartner et al. | Aug 1994 | A |
| 5337747 | Neftel | Aug 1994 | A |
| 5337919 | Spaulding et al. | Aug 1994 | A |
| 5338157 | Blomquist | Aug 1994 | A |
| 5339421 | Housel, III | Aug 1994 | A |
| 5339821 | Fujimoto | Aug 1994 | A |
| 5341291 | Roizen et al. | Aug 1994 | A |
| 5341412 | Ramot et al. | Aug 1994 | A |
| 5348008 | Bornn et al. | Sep 1994 | A |
| 5348539 | Herskowitz | Sep 1994 | A |
| 5349675 | Fitzgerald et al. | Sep 1994 | A |
| 5356378 | Doan | Oct 1994 | A |
| 5360410 | Wacks | Nov 1994 | A |
| 5361202 | Doue | Nov 1994 | A |
| 5361758 | Hall et al. | Nov 1994 | A |
| 5366896 | Margrey et al. | Nov 1994 | A |
| 5366904 | Qureshi et al. | Nov 1994 | A |
| 5367555 | Isoyama | Nov 1994 | A |
| 5368562 | Blomquist et al. | Nov 1994 | A |
| 5370612 | Maeda et al. | Dec 1994 | A |
| 5371687 | Holmes, II et al. | Dec 1994 | A |
| 5374251 | Smith | Dec 1994 | A |
| 5374813 | Shipp | Dec 1994 | A |
| 5374965 | Kanno | Dec 1994 | A |
| 5375604 | Kelly et al. | Dec 1994 | A |
| 5376070 | Purvis et al. | Dec 1994 | A |
| 5377864 | Blechl et al. | Jan 1995 | A |
| 5378231 | Johnson et al. | Jan 1995 | A |
| 5379214 | Arbuckle et al. | Jan 1995 | A |
| 5389078 | Zalesky et al. | Feb 1995 | A |
| 5390238 | Kirk et al. | Feb 1995 | A |
| 5392951 | Gardner et al. | Feb 1995 | A |
| 5395320 | Padda et al. | Mar 1995 | A |
| 5395321 | Kawahara et al. | Mar 1995 | A |
| 5398336 | Tantry et al. | Mar 1995 | A |
| 5401059 | Ferrario | Mar 1995 | A |
| 5404292 | Hendrickson | Apr 1995 | A |
| 5404384 | Colburn et al. | Apr 1995 | A |
| 5406473 | Yoshikura et al. | Apr 1995 | A |
| 5412715 | Volpe | May 1995 | A |
| 5415167 | Wilk | May 1995 | A |
| 5416695 | Stutman et al. | May 1995 | A |
| 5417222 | Dempsey et al. | May 1995 | A |
| 5420977 | Sztipanovits et al. | May 1995 | A |
| 5421343 | Feng | Jun 1995 | A |
| 5423746 | Burkett et al. | Jun 1995 | A |
| 5429602 | Hauser | Jul 1995 | A |
| 5431201 | Torchia et al. | Jul 1995 | A |
| 5431299 | Brewer et al. | Jul 1995 | A |
| 5431627 | Pastrone et al. | Jul 1995 | A |
| 5433736 | Nilsson | Jul 1995 | A |
| 5438607 | Przygoda, Jr. et al. | Aug 1995 | A |
| 5440699 | Farrand et al. | Aug 1995 | A |
| 5441047 | David et al. | Aug 1995 | A |
| 5445294 | Gardner et al. | Aug 1995 | A |
| 5445621 | Poli et al. | Aug 1995 | A |
| 5446868 | Gardea, II et al. | Aug 1995 | A |
| 5453098 | Botts et al. | Sep 1995 | A |
| 5455851 | Chaco et al. | Oct 1995 | A |
| 5458123 | Unger | Oct 1995 | A |
| 5460294 | Williams | Oct 1995 | A |
| 5460605 | Tuttle et al. | Oct 1995 | A |
| 5461665 | Shur et al. | Oct 1995 | A |
| 5462051 | Oka et al. | Oct 1995 | A |
| 5464392 | Epstein et al. | Nov 1995 | A |
| 5465286 | Clare et al. | Nov 1995 | A |
| 5467773 | Bergelson et al. | Nov 1995 | A |
| 5468110 | McDonald et al. | Nov 1995 | A |
| 5469855 | Pompei et al. | Nov 1995 | A |
| 5471382 | Tallman et al. | Nov 1995 | A |
| 5474552 | Palti | Dec 1995 | A |
| 5482043 | Zulauf | Jan 1996 | A |
| 5482446 | Williamson et al. | Jan 1996 | A |
| 5485408 | Blomquist | Jan 1996 | A |
| 5490610 | Pearson | Feb 1996 | A |
| 5494592 | Latham, Jr. et al. | Feb 1996 | A |
| 5496265 | Langley et al. | Mar 1996 | A |
| 5496273 | Pastrone et al. | Mar 1996 | A |
| 5502944 | Kraft et al. | Apr 1996 | A |
| 5507412 | Ebert et al. | Apr 1996 | A |
| 5508912 | Schneiderman | Apr 1996 | A |
| 5509318 | Gomes | Apr 1996 | A |
| 5509422 | Fukami | Apr 1996 | A |
| 5513957 | O'Leary | May 1996 | A |
| 5514088 | Zakko | May 1996 | A |
| 5514095 | Brightbill et al. | May 1996 | A |
| 5515426 | Yacenda et al. | May 1996 | A |
| 5520450 | Colson, Jr. et al. | May 1996 | A |
| 5520637 | Pager et al. | May 1996 | A |
| 5522396 | Langer et al. | Jun 1996 | A |
| 5522798 | Johnson et al. | Jun 1996 | A |
| 5526428 | Arnold | Jun 1996 | A |
| 5528503 | Moore et al. | Jun 1996 | A |
| 5529063 | Hill | Jun 1996 | A |
| 5531680 | Dumas et al. | Jul 1996 | A |
| 5531697 | Olsen et al. | Jul 1996 | A |
| 5531698 | Olsen | Jul 1996 | A |
| 5533079 | Colburn et al. | Jul 1996 | A |
| 5533981 | Mandro et al. | Jul 1996 | A |
| 5534691 | Holdaway et al. | Jul 1996 | A |
| 5536084 | Curtis et al. | Jul 1996 | A |
| 5537313 | Pirelli | Jul 1996 | A |
| 5537853 | Finburgh et al. | Jul 1996 | A |
| 5542420 | Goldman et al. | Aug 1996 | A |
| 5544649 | David et al. | Aug 1996 | A |
| 5544651 | Wilk | Aug 1996 | A |
| 5544661 | Davis et al. | Aug 1996 | A |
| 5545140 | Conero et al. | Aug 1996 | A |
| 5546580 | Seliger et al. | Aug 1996 | A |
| 5547470 | Johnson et al. | Aug 1996 | A |
| 5549117 | Tacklind et al. | Aug 1996 | A |
| 5549460 | O'Leary | Aug 1996 | A |
| 5553609 | Chen et al. | Sep 1996 | A |
| 5558638 | Evers et al. | Sep 1996 | A |
| 5558640 | Pfeiler et al. | Sep 1996 | A |
| 5560352 | Heim et al. | Oct 1996 | A |
| 5562232 | Pearson | Oct 1996 | A |
| 5562621 | Claude et al. | Oct 1996 | A |
| 5563347 | Martin et al. | Oct 1996 | A |
| 5564434 | Halperin et al. | Oct 1996 | A |
| 5564803 | McDonald et al. | Oct 1996 | A |
| 5568912 | Minami et al. | Oct 1996 | A |
| 5569186 | Lord et al. | Oct 1996 | A |
| 5569187 | Kaiser | Oct 1996 | A |
| 5571258 | Pearson | Nov 1996 | A |
| 5573502 | LeCocq et al. | Nov 1996 | A |
| 5573506 | Vasko | Nov 1996 | A |
| 5575632 | Morris et al. | Nov 1996 | A |
| 5576952 | Stutman et al. | Nov 1996 | A |
| 5579001 | Dempsey et al. | Nov 1996 | A |
| 5579378 | Arlinghaus, Jr. | Nov 1996 | A |
| 5581369 | Righter et al. | Dec 1996 | A |
| 5581687 | Lyle et al. | Dec 1996 | A |
| 5582593 | Hultman | Dec 1996 | A |
| 5583758 | Mcilroy et al. | Dec 1996 | A |
| 5588815 | Zaleski, II | Dec 1996 | A |
| 5589932 | Garcia-Rubio et al. | Dec 1996 | A |
| 5590648 | Mitchell et al. | Jan 1997 | A |
| 5591344 | Kenley et al. | Jan 1997 | A |
| 5593267 | McDonald et al. | Jan 1997 | A |
| 5594637 | Eisenberg et al. | Jan 1997 | A |
| 5594786 | Chaco et al. | Jan 1997 | A |
| 5597995 | Williams et al. | Jan 1997 | A |
| 5598536 | Slaughter, III et al. | Jan 1997 | A |
| 5601445 | Schipper et al. | Feb 1997 | A |
| 5609575 | Larson et al. | Mar 1997 | A |
| 5609576 | Voss et al. | Mar 1997 | A |
| 5613115 | Gihl et al. | Mar 1997 | A |
| 5619428 | Lee et al. | Apr 1997 | A |
| 5619991 | Sloane | Apr 1997 | A |
| 5623652 | Vora et al. | Apr 1997 | A |
| 5623925 | Swenson et al. | Apr 1997 | A |
| 5626144 | Tacklind et al. | May 1997 | A |
| 5628619 | Wilson | May 1997 | A |
| 5630710 | Tune et al. | May 1997 | A |
| 5631844 | Margrey et al. | May 1997 | A |
| 5633910 | Cohen | May 1997 | A |
| D380260 | Hyman | Jun 1997 | S |
| 5634893 | Rishton | Jun 1997 | A |
| 5637082 | Pages et al. | Jun 1997 | A |
| 5637093 | Hyman et al. | Jun 1997 | A |
| 5640301 | Roecher et al. | Jun 1997 | A |
| 5640953 | Bishop et al. | Jun 1997 | A |
| 5641628 | Bianchi | Jun 1997 | A |
| 5643193 | Papillon et al. | Jul 1997 | A |
| 5643212 | Coutre et al. | Jul 1997 | A |
| 5647853 | Feldmann et al. | Jul 1997 | A |
| 5647854 | Olsen et al. | Jul 1997 | A |
| 5651775 | Walker et al. | Jul 1997 | A |
| 5652566 | Lambert | Jul 1997 | A |
| 5658240 | Urdahl et al. | Aug 1997 | A |
| 5658250 | Blomquist et al. | Aug 1997 | A |
| 5661978 | Holmes et al. | Sep 1997 | A |
| 5664270 | Bell et al. | Sep 1997 | A |
| 5666404 | Ciccotelli et al. | Sep 1997 | A |
| D385646 | Chan | Oct 1997 | S |
| 5678562 | Sellers | Oct 1997 | A |
| 5678568 | Uchikubo et al. | Oct 1997 | A |
| 5681285 | Ford et al. | Oct 1997 | A |
| 5682526 | Smokoff et al. | Oct 1997 | A |
| 5683367 | Jordan et al. | Nov 1997 | A |
| 5685844 | Marttila | Nov 1997 | A |
| 5687717 | Halpern | Nov 1997 | A |
| 5687734 | Dempsey et al. | Nov 1997 | A |
| 5695473 | Olsen | Dec 1997 | A |
| 5697951 | Harpstead | Dec 1997 | A |
| 5700998 | Palti | Dec 1997 | A |
| 5701894 | Cherry et al. | Dec 1997 | A |
| 5704351 | Mortara et al. | Jan 1998 | A |
| 5704364 | Saltzstein et al. | Jan 1998 | A |
| 5704366 | Tacklind et al. | Jan 1998 | A |
| 5712798 | Langley et al. | Jan 1998 | A |
| 5712912 | Tomko et al. | Jan 1998 | A |
| 5713485 | Liff et al. | Feb 1998 | A |
| 5713856 | Eggers et al. | Feb 1998 | A |
| 5715823 | Wood et al. | Feb 1998 | A |
| 5716114 | Holmes et al. | Feb 1998 | A |
| 5716194 | Butterfield et al. | Feb 1998 | A |
| 5718562 | Lawless et al. | Feb 1998 | A |
| 5719761 | Gatti et al. | Feb 1998 | A |
| RE35743 | Pearson | Mar 1998 | E |
| 5724025 | Tavori | Mar 1998 | A |
| 5724580 | Levin et al. | Mar 1998 | A |
| 5732709 | Tacklind et al. | Mar 1998 | A |
| 5733259 | Valcke et al. | Mar 1998 | A |
| 5735887 | Barreras, Sr. et al. | Apr 1998 | A |
| 5737539 | Edelson et al. | Apr 1998 | A |
| 5740185 | Bosse | Apr 1998 | A |
| 5740800 | Hendrickson et al. | Apr 1998 | A |
| 5745366 | Higham et al. | Apr 1998 | A |
| 5745378 | Barker et al. | Apr 1998 | A |
| 5752917 | Fuchs | May 1998 | A |
| 5752976 | Duffin et al. | May 1998 | A |
| 5755563 | Clegg et al. | May 1998 | A |
| 5758095 | Albaum et al. | May 1998 | A |
| 5764923 | Tallman et al. | Jun 1998 | A |
| 5766155 | Hyman et al. | Jun 1998 | A |
| 5769811 | Stacey et al. | Jun 1998 | A |
| 5771657 | Lasher et al. | Jun 1998 | A |
| 5772585 | Lavin et al. | Jun 1998 | A |
| 5772586 | Heinonen et al. | Jun 1998 | A |
| 5772635 | Dastur et al. | Jun 1998 | A |
| 5772637 | Heinzmann et al. | Jun 1998 | A |
| 5776057 | Swenson et al. | Jul 1998 | A |
| 5778345 | McCartney | Jul 1998 | A |
| 5778882 | Raymond et al. | Jul 1998 | A |
| 5781442 | Engleson et al. | Jul 1998 | A |
| 5782805 | Meinzer et al. | Jul 1998 | A |
| 5782878 | Morgan et al. | Jul 1998 | A |
| 5785650 | Akasaka et al. | Jul 1998 | A |
| 5788669 | Peterson | Aug 1998 | A |
| 5788851 | Kenley et al. | Aug 1998 | A |
| 5790409 | Fedor et al. | Aug 1998 | A |
| 5791342 | Woodard | Aug 1998 | A |
| 5791880 | Wilson | Aug 1998 | A |
| 5793861 | Haigh | Aug 1998 | A |
| 5793969 | Kamentsky et al. | Aug 1998 | A |
| 5795317 | Brierton et al. | Aug 1998 | A |
| 5795327 | Wilson et al. | Aug 1998 | A |
| 5797515 | Liff et al. | Aug 1998 | A |
| 5800387 | Duffy et al. | Sep 1998 | A |
| 5801755 | Echerer | Sep 1998 | A |
| 5803906 | Pratt et al. | Sep 1998 | A |
| 5805442 | Crater et al. | Sep 1998 | A |
| 5805454 | Valerino et al. | Sep 1998 | A |
| 5805456 | Higham et al. | Sep 1998 | A |
| 5805505 | Zheng et al. | Sep 1998 | A |
| 5807321 | Stoker et al. | Sep 1998 | A |
| 5807322 | Lindsey et al. | Sep 1998 | A |
| 5807336 | Russo et al. | Sep 1998 | A |
| 5810747 | Brudny et al. | Sep 1998 | A |
| 5812410 | Lion et al. | Sep 1998 | A |
| 5814015 | Gargano et al. | Sep 1998 | A |
| 5815566 | Ramot et al. | Sep 1998 | A |
| 5818528 | Roth et al. | Oct 1998 | A |
| 5822418 | Yacenda et al. | Oct 1998 | A |
| 5822544 | Chaco et al. | Oct 1998 | A |
| 5823949 | Goltra | Oct 1998 | A |
| 5826237 | Macrae et al. | Oct 1998 | A |
| 5829438 | Gibbs et al. | Nov 1998 | A |
| 5832447 | Rieker et al. | Nov 1998 | A |
| 5832448 | Brown | Nov 1998 | A |
| 5832450 | Myers et al. | Nov 1998 | A |
| 5833599 | Schrier et al. | Nov 1998 | A |
| 5835897 | Dang | Nov 1998 | A |
| 5836910 | Duffy et al. | Nov 1998 | A |
| 5841975 | Layne et al. | Nov 1998 | A |
| 5842841 | Danby et al. | Dec 1998 | A |
| 5842976 | Williamson | Dec 1998 | A |
| 5845253 | Rensimer et al. | Dec 1998 | A |
| 5848593 | McGrady et al. | Dec 1998 | A |
| 5851186 | Wood et al. | Dec 1998 | A |
| 5852590 | De La Huerga | Dec 1998 | A |
| 5853387 | Clegg et al. | Dec 1998 | A |
| 5855550 | Lai et al. | Jan 1999 | A |
| 5857967 | Frid et al. | Jan 1999 | A |
| 5859972 | Subramaniam et al. | Jan 1999 | A |
| 5865745 | Schmitt et al. | Feb 1999 | A |
| 5865786 | Sibalis et al. | Feb 1999 | A |
| 5867821 | Ballantyne et al. | Feb 1999 | A |
| 5871465 | Vasko | Feb 1999 | A |
| 5876926 | Beecham | Mar 1999 | A |
| 5880443 | McDonald et al. | Mar 1999 | A |
| 5882338 | Gray | Mar 1999 | A |
| 5883370 | Walker et al. | Mar 1999 | A |
| 5883576 | De La Huerga | Mar 1999 | A |
| 5884273 | Sattizahn et al. | Mar 1999 | A |
| 5884457 | Ortiz et al. | Mar 1999 | A |
| 5885245 | Lynch et al. | Mar 1999 | A |
| 5891035 | Wood et al. | Apr 1999 | A |
| 5891734 | Gill et al. | Apr 1999 | A |
| 5893697 | Zimi et al. | Apr 1999 | A |
| 5894273 | Meador et al. | Apr 1999 | A |
| 5895371 | Levitas et al. | Apr 1999 | A |
| 5897493 | Brown | Apr 1999 | A |
| 5897530 | Jackson | Apr 1999 | A |
| 5897989 | Beecham | Apr 1999 | A |
| 5899665 | Makino et al. | May 1999 | A |
| 5899855 | Brown | May 1999 | A |
| 5901150 | Jhuboo et al. | May 1999 | A |
| 5904668 | Hyman et al. | May 1999 | A |
| 5905653 | Higham et al. | May 1999 | A |
| 5907291 | Chen et al. | May 1999 | A |
| 5907493 | Boyer et al. | May 1999 | A |
| 5908027 | Butterfield et al. | Jun 1999 | A |
| 5910107 | Iliff | Jun 1999 | A |
| 5910252 | Truitt et al. | Jun 1999 | A |
| 5911132 | Sloane | Jun 1999 | A |
| 5911687 | Sato et al. | Jun 1999 | A |
| 5912818 | McGrady et al. | Jun 1999 | A |
| 5913197 | Kameda | Jun 1999 | A |
| 5913310 | Brown | Jun 1999 | A |
| 5915089 | Stevens et al. | Jun 1999 | A |
| 5915240 | Karpf | Jun 1999 | A |
| 5919154 | Toays et al. | Jul 1999 | A |
| 5921938 | Aoyama et al. | Jul 1999 | A |
| 5923018 | Kameda et al. | Jul 1999 | A |
| 5924074 | Evans | Jul 1999 | A |
| 5924103 | Ahmed et al. | Jul 1999 | A |
| 5927540 | Godlewski | Jul 1999 | A |
| 5931791 | Saltzstein et al. | Aug 1999 | A |
| 5935060 | Iliff | Aug 1999 | A |
| 5935099 | Peterson et al. | Aug 1999 | A |
| 5935106 | Olsen | Aug 1999 | A |
| 5938413 | Makino et al. | Aug 1999 | A |
| 5939326 | Chupp et al. | Aug 1999 | A |
| 5939699 | Perttunen et al. | Aug 1999 | A |
| 5940306 | Gardner et al. | Aug 1999 | A |
| 5940802 | Hildebrand et al. | Aug 1999 | A |
| 5941829 | Saltzstein et al. | Aug 1999 | A |
| 5941846 | Duffy et al. | Aug 1999 | A |
| 5942986 | Shabot et al. | Aug 1999 | A |
| 5943423 | Muftic | Aug 1999 | A |
| 5943633 | Wilson et al. | Aug 1999 | A |
| 5944659 | Flach et al. | Aug 1999 | A |
| 5945651 | Chorosinski et al. | Aug 1999 | A |
| 5946083 | Melendez et al. | Aug 1999 | A |
| 5946659 | Lancelot et al. | Aug 1999 | A |
| D414578 | Chen et al. | Sep 1999 | S |
| 5950006 | Crater et al. | Sep 1999 | A |
| 5951300 | Brown | Sep 1999 | A |
| 5951510 | Barak | Sep 1999 | A |
| 5954640 | Szabo | Sep 1999 | A |
| 5954885 | Bollish et al. | Sep 1999 | A |
| 5954971 | Pages et al. | Sep 1999 | A |
| 5956023 | Lyle et al. | Sep 1999 | A |
| 5957885 | Bollish et al. | Sep 1999 | A |
| 5959529 | Kail, IV | Sep 1999 | A |
| 5960085 | de la Huerga | Sep 1999 | A |
| 5960403 | Brown | Sep 1999 | A |
| 5960991 | Ophardt | Oct 1999 | A |
| 5961446 | Beller et al. | Oct 1999 | A |
| 5961448 | Swenson et al. | Oct 1999 | A |
| 5961487 | Davis | Oct 1999 | A |
| 5961923 | Nova et al. | Oct 1999 | A |
| 5963641 | Crandall et al. | Oct 1999 | A |
| 5964700 | Tallman et al. | Oct 1999 | A |
| 5966304 | Cook et al. | Oct 1999 | A |
| 5967975 | Ridgeway | Oct 1999 | A |
| 5970423 | Langley et al. | Oct 1999 | A |
| 5971593 | McGrady | Oct 1999 | A |
| 5971921 | Timbel | Oct 1999 | A |
| 5971948 | Pages et al. | Oct 1999 | A |
| 5974124 | Schlueter, Jr. et al. | Oct 1999 | A |
| 5975737 | Crater et al. | Nov 1999 | A |
| 5980490 | Tsoukalis | Nov 1999 | A |
| 5983193 | Heinonen et al. | Nov 1999 | A |
| 5987519 | Peifer et al. | Nov 1999 | A |
| 5991731 | Colon et al. | Nov 1999 | A |
| 5993046 | McGrady et al. | Nov 1999 | A |
| 5993420 | Hyman et al. | Nov 1999 | A |
| 5995077 | Wilcox et al. | Nov 1999 | A |
| 5995939 | Berman et al. | Nov 1999 | A |
| 5995965 | Experton | Nov 1999 | A |
| 5997167 | Crater et al. | Dec 1999 | A |
| 5997476 | Brown | Dec 1999 | A |
| 6003006 | Colella et al. | Dec 1999 | A |
| 6004020 | Bartur | Dec 1999 | A |
| 6004276 | Wright et al. | Dec 1999 | A |
| 6006191 | DeRienzo | Dec 1999 | A |
| 6006946 | Williams et al. | Dec 1999 | A |
| 6009333 | Chaco | Dec 1999 | A |
| 6010454 | Arieff et al. | Jan 2000 | A |
| 6011858 | Stock et al. | Jan 2000 | A |
| 6011999 | Holmes | Jan 2000 | A |
| 6012034 | Hamparian et al. | Jan 2000 | A |
| 6013057 | Danby et al. | Jan 2000 | A |
| 6014631 | Teagarden et al. | Jan 2000 | A |
| 6016444 | John | Jan 2000 | A |
| 6017318 | Gauthier et al. | Jan 2000 | A |
| 6018713 | Coli et al. | Jan 2000 | A |
| 6019745 | Gray | Feb 2000 | A |
| 6021392 | Lester et al. | Feb 2000 | A |
| 6022315 | Iliff | Feb 2000 | A |
| 6023522 | Draganoff et al. | Feb 2000 | A |
| 6024539 | Blomquist | Feb 2000 | A |
| 6024699 | Surwit et al. | Feb 2000 | A |
| 6027217 | McClure et al. | Feb 2000 | A |
| 6029138 | Khorasani et al. | Feb 2000 | A |
| 6032119 | Brown et al. | Feb 2000 | A |
| 6032155 | de la Huerga | Feb 2000 | A |
| 6033076 | Braeuning et al. | Mar 2000 | A |
| 6039251 | Holowko et al. | Mar 2000 | A |
| 6039467 | Holmes | Mar 2000 | A |
| 6047259 | Campbell et al. | Apr 2000 | A |
| 6048086 | Valerino | Apr 2000 | A |
| 6050940 | Braun et al. | Apr 2000 | A |
| 6055487 | Margery et al. | Apr 2000 | A |
| 6057758 | Dempsey et al. | May 2000 | A |
| 6059736 | Tapper | May 2000 | A |
| 6061603 | Papadopoulos et al. | May 2000 | A |
| 6065819 | Holmes et al. | May 2000 | A |
| 6068153 | Young et al. | May 2000 | A |
| 6068156 | Liff et al. | May 2000 | A |
| 6073046 | Patel et al. | Jun 2000 | A |
| 6074345 | van Oostrom et al. | Jun 2000 | A |
| 6079621 | Vardanyan et al. | Jun 2000 | A |
| 6080106 | Lloyd et al. | Jun 2000 | A |
| 6081048 | Bergmann et al. | Jun 2000 | A |
| 6081786 | Barry et al. | Jun 2000 | A |
| 6082776 | Feinberg | Jul 2000 | A |
| 6083206 | Molko | Jul 2000 | A |
| 6093146 | Filangeri | Jul 2000 | A |
| 6095985 | Raymond et al. | Aug 2000 | A |
| 6096561 | Tayi | Aug 2000 | A |
| 6098892 | Peoples, Jr. | Aug 2000 | A |
| 6101407 | Groezinger | Aug 2000 | A |
| 6101478 | Brown | Aug 2000 | A |
| 6102856 | Groff et al. | Aug 2000 | A |
| 6108399 | Hernandez-Guerra et al. | Aug 2000 | A |
| 6108588 | McGrady | Aug 2000 | A |
| 6109774 | Holmes et al. | Aug 2000 | A |
| 6112224 | Peifer et al. | Aug 2000 | A |
| RE36871 | Epstein et al. | Sep 2000 | E |
| 6113554 | Gilcher et al. | Sep 2000 | A |
| 6116461 | Broadfield et al. | Sep 2000 | A |
| 6117940 | Mjalli | Sep 2000 | A |
| 6123524 | Danby et al. | Sep 2000 | A |
| 6125350 | Dirbas | Sep 2000 | A |
| 6129517 | Danby et al. | Oct 2000 | A |
| 6132371 | Dempsey et al. | Oct 2000 | A |
| 6134504 | Douglas et al. | Oct 2000 | A |
| 6135949 | Russo et al. | Oct 2000 | A |
| 6139177 | Venkatraman et al. | Oct 2000 | A |
| 6139495 | De La Huerga | Oct 2000 | A |
| 6141412 | Smith et al. | Oct 2000 | A |
| 6144922 | Douglas et al. | Nov 2000 | A |
| 6145695 | Garrigues | Nov 2000 | A |
| 6146523 | Kenley et al. | Nov 2000 | A |
| 6148297 | Swor et al. | Nov 2000 | A |
| 6149063 | Reynolds et al. | Nov 2000 | A |
| 6151536 | Arnold et al. | Nov 2000 | A |
| 6152364 | Schoonen et al. | Nov 2000 | A |
| 6154668 | Pedersen et al. | Nov 2000 | A |
| 6154726 | Rensimer et al. | Nov 2000 | A |
| 6157914 | Seto et al. | Dec 2000 | A |
| 6158965 | Butterfield et al. | Dec 2000 | A |
| 6160478 | Jacobsen et al. | Dec 2000 | A |
| 6161095 | Brown | Dec 2000 | A |
| 6161141 | Dillon | Dec 2000 | A |
| 6163737 | Fedor et al. | Dec 2000 | A |
| 6165154 | Gray et al. | Dec 2000 | A |
| 6168563 | Brown | Jan 2001 | B1 |
| 6170007 | Venkatraman et al. | Jan 2001 | B1 |
| 6170746 | Brook et al. | Jan 2001 | B1 |
| 6171112 | Clark et al. | Jan 2001 | B1 |
| 6171237 | Avitall et al. | Jan 2001 | B1 |
| 6171264 | Bader | Jan 2001 | B1 |
| 6173198 | Schulze et al. | Jan 2001 | B1 |
| 6175779 | Barrett | Jan 2001 | B1 |
| 6175977 | Schumacher et al. | Jan 2001 | B1 |
| 6176392 | William et al. | Jan 2001 | B1 |
| 6182047 | Dirbas | Jan 2001 | B1 |
| 6183417 | Geheb et al. | Feb 2001 | B1 |
| 6186145 | Brown | Feb 2001 | B1 |
| 6192320 | Margrey et al. | Feb 2001 | B1 |
| 6193480 | Butterfield | Feb 2001 | B1 |
| 6195887 | Danby et al. | Mar 2001 | B1 |
| 6198394 | Jacobsen et al. | Mar 2001 | B1 |
| 6200264 | Satherley et al. | Mar 2001 | B1 |
| 6200289 | Hochman et al. | Mar 2001 | B1 |
| 6202923 | Boyer et al. | Mar 2001 | B1 |
| 6203495 | Bardy | Mar 2001 | B1 |
| 6203528 | Deckert et al. | Mar 2001 | B1 |
| 6206238 | Ophardt | Mar 2001 | B1 |
| 6206829 | Iliff | Mar 2001 | B1 |
| 6210361 | Kamen et al. | Apr 2001 | B1 |
| 6213391 | Lewis | Apr 2001 | B1 |
| 6213738 | Danby et al. | Apr 2001 | B1 |
| 6213972 | Butterfield et al. | Apr 2001 | B1 |
| 6219439 | Burger | Apr 2001 | B1 |
| 6219587 | Ahlin et al. | Apr 2001 | B1 |
| 6221009 | Doi et al. | Apr 2001 | B1 |
| 6221011 | Bardy | Apr 2001 | B1 |
| 6221012 | Maschke et al. | Apr 2001 | B1 |
| 6222619 | Herron et al. | Apr 2001 | B1 |
| 6224549 | Drongelen | May 2001 | B1 |
| 6225901 | Kail, IV | May 2001 | B1 |
| 6226564 | Stuart | May 2001 | B1 |
| 6226745 | Wiederhold | May 2001 | B1 |
| 6230142 | Benigno et al. | May 2001 | B1 |
| 6230927 | Schoonen et al. | May 2001 | B1 |
| 6234997 | Kamen et al. | May 2001 | B1 |
| 6245013 | Minoz et al. | Jun 2001 | B1 |
| 6246473 | Smith, Jr. et al. | Jun 2001 | B1 |
| 6248063 | Barnhill et al. | Jun 2001 | B1 |
| 6248065 | Brown | Jun 2001 | B1 |
| 6255951 | De La Huerga | Jul 2001 | B1 |
| 6256643 | Cork et al. | Jul 2001 | B1 |
| 6256967 | Hebron et al. | Jul 2001 | B1 |
| 6259355 | Chaco et al. | Jul 2001 | B1 |
| 6259654 | De La Huerga | Jul 2001 | B1 |
| 6260021 | Wong et al. | Jul 2001 | B1 |
| 6266645 | Simpson | Jul 2001 | B1 |
| 6269340 | Ford et al. | Jul 2001 | B1 |
| D446854 | Cheney, II et al. | Aug 2001 | S |
| 6270455 | Brown | Aug 2001 | B1 |
| 6270457 | Bardy | Aug 2001 | B1 |
| 6272394 | Lipps | Aug 2001 | B1 |
| 6272505 | De La Huerga | Aug 2001 | B1 |
| 6277072 | Bardy | Aug 2001 | B1 |
| 6278999 | Knapp | Aug 2001 | B1 |
| 6283322 | Liff et al. | Sep 2001 | B1 |
| 6283944 | McMullen et al. | Sep 2001 | B1 |
| 6290646 | Cosentino et al. | Sep 2001 | B1 |
| 6290650 | Butterfield et al. | Sep 2001 | B1 |
| 6294999 | Yarin et al. | Sep 2001 | B1 |
| 6295506 | Heinonen | Sep 2001 | B1 |
| 6304788 | Eady et al. | Oct 2001 | B1 |
| 6306088 | Krausman et al. | Oct 2001 | B1 |
| 6307956 | Black | Oct 2001 | B1 |
| 6308171 | De La Huerga | Oct 2001 | B1 |
| 6311163 | Sheehan et al. | Oct 2001 | B1 |
| 6312227 | Davis | Nov 2001 | B1 |
| 6312378 | Bardy | Nov 2001 | B1 |
| 6314384 | Goetz | Nov 2001 | B1 |
| 6317719 | Schrier et al. | Nov 2001 | B1 |
| 6319200 | Lai et al. | Nov 2001 | B1 |
| 6321203 | Kameda | Nov 2001 | B1 |
| 6322502 | Schoenberg et al. | Nov 2001 | B1 |
| 6322504 | Kirshner | Nov 2001 | B1 |
| 6322515 | Goor et al. | Nov 2001 | B1 |
| 6330491 | Lion | Dec 2001 | B1 |
| 6332090 | DeFrank et al. | Dec 2001 | B1 |
| RE37531 | Chaco et al. | Jan 2002 | E |
| 6337631 | Pai et al. | Jan 2002 | B1 |
| 6338007 | Broadfield et al. | Jan 2002 | B1 |
| 6339732 | Phoon et al. | Jan 2002 | B1 |
| 6345260 | Cummings, Jr. et al. | Feb 2002 | B1 |
| 6346886 | De La Huerga | Feb 2002 | B1 |
| 6347553 | Morris et al. | Feb 2002 | B1 |
| 6352200 | Schoonen et al. | Mar 2002 | B1 |
| 6353817 | Jacobs et al. | Mar 2002 | B1 |
| 6358225 | Butterfield | Mar 2002 | B1 |
| 6358237 | Paukovits et al. | Mar 2002 | B1 |
| 6361263 | Dewey et al. | Mar 2002 | B1 |
| 6362591 | Moberg | Mar 2002 | B1 |
| 6363282 | Nichols et al. | Mar 2002 | B1 |
| 6363290 | Lyle et al. | Mar 2002 | B1 |
| 6364834 | Reuss et al. | Apr 2002 | B1 |
| 6368273 | Brown | Apr 2002 | B1 |
| 6370841 | Chudy et al. | Apr 2002 | B1 |
| 6381577 | Brown | Apr 2002 | B1 |
| 6385505 | Lipps | May 2002 | B1 |
| 6393369 | Carr | May 2002 | B1 |
| 6397190 | Goetz | May 2002 | B1 |
| 6401072 | Haudenschild et al. | Jun 2002 | B1 |
| 6402702 | Gilcher et al. | Jun 2002 | B1 |
| 6406426 | Reuss et al. | Jun 2002 | B1 |
| 6407335 | Franklin-Lees et al. | Jun 2002 | B1 |
| 6408330 | DeLaHuerga | Jun 2002 | B1 |
| 6416471 | Kumar et al. | Jul 2002 | B1 |
| 6421650 | Goetz et al. | Jul 2002 | B1 |
| 6424996 | Killcommons et al. | Jul 2002 | B1 |
| 6427088 | Bowman, IV et al. | Jul 2002 | B1 |
| 6434531 | Lancelot et al. | Aug 2002 | B1 |
| 6434569 | Tomlinson et al. | Aug 2002 | B1 |
| 6438451 | Lion | Aug 2002 | B1 |
| RE37829 | Charhut et al. | Sep 2002 | E |
| 6449927 | Hebron et al. | Sep 2002 | B2 |
| 6450956 | Rappaport et al. | Sep 2002 | B1 |
| 6458102 | Mann et al. | Oct 2002 | B1 |
| 6461037 | O'Leary | Oct 2002 | B1 |
| 6463310 | Swedlow et al. | Oct 2002 | B1 |
| 6468242 | Wilson et al. | Oct 2002 | B1 |
| 6470234 | McGrady | Oct 2002 | B1 |
| 6471089 | Liff et al. | Oct 2002 | B2 |
| 6471645 | Warkentin et al. | Oct 2002 | B1 |
| 6471646 | Thede | Oct 2002 | B1 |
| 6475146 | Frelburger et al. | Nov 2002 | B1 |
| 6475148 | Jackson et al. | Nov 2002 | B1 |
| 6475180 | Peterson et al. | Nov 2002 | B2 |
| 6478737 | Bardy | Nov 2002 | B2 |
| 6485465 | Moberg et al. | Nov 2002 | B2 |
| 6494831 | Koritzinsky | Dec 2002 | B1 |
| 6511138 | Gardner et al. | Jan 2003 | B1 |
| 6519569 | White et al. | Feb 2003 | B1 |
| 6537244 | Paukovits | Mar 2003 | B2 |
| 6542902 | Dulong et al. | Apr 2003 | B2 |
| 6542910 | Cork et al. | Apr 2003 | B2 |
| 6544174 | West et al. | Apr 2003 | B2 |
| 6544228 | Heitmeier | Apr 2003 | B1 |
| 6551243 | Bocionek et al. | Apr 2003 | B2 |
| 6551276 | Mann et al. | Apr 2003 | B1 |
| 6554791 | Cartledge et al. | Apr 2003 | B1 |
| 6554798 | Mann et al. | Apr 2003 | B1 |
| 6555986 | Moberg | Apr 2003 | B2 |
| 6558321 | Burd et al. | May 2003 | B1 |
| 6561975 | Pool et al. | May 2003 | B1 |
| 6562001 | Lebel et al. | May 2003 | B2 |
| 6564104 | Nelson et al. | May 2003 | B2 |
| 6564105 | Starkweather et al. | May 2003 | B2 |
| 6564121 | Wallace et al. | May 2003 | B1 |
| 6571128 | Lebel et al. | May 2003 | B2 |
| 6575900 | Zweig et al. | Jun 2003 | B1 |
| 6577899 | Lebel et al. | Jun 2003 | B2 |
| 6579232 | Sakamaki et al. | Jun 2003 | B2 |
| 6581069 | Robinson et al. | Jun 2003 | B1 |
| 6581798 | Liff et al. | Jun 2003 | B2 |
| 6584336 | Ali et al. | Jun 2003 | B1 |
| 6585157 | Brandt et al. | Jul 2003 | B2 |
| 6585644 | Lebel et al. | Jul 2003 | B2 |
| 6585675 | O'Mahony et al. | Jul 2003 | B1 |
| 6592551 | Cobb | Jul 2003 | B1 |
| 6593528 | Franklin-Lees et al. | Jul 2003 | B2 |
| 6602469 | Maus et al. | Aug 2003 | B1 |
| 6607485 | Bardy | Aug 2003 | B2 |
| 6610973 | Davis, III | Aug 2003 | B1 |
| 6613009 | Bainbridge et al. | Sep 2003 | B1 |
| 6616633 | Butterfield et al. | Sep 2003 | B1 |
| 6635014 | Starkweather et al. | Oct 2003 | B2 |
| 6648821 | Lebel et al. | Nov 2003 | B2 |
| 6659948 | Lebel et al. | Dec 2003 | B2 |
| 6664893 | Eveland et al. | Dec 2003 | B1 |
| 6668196 | Villegas et al. | Dec 2003 | B1 |
| 6669663 | Thompson | Dec 2003 | B1 |
| 6673314 | Burbank et al. | Jan 2004 | B1 |
| 6687546 | Lebel et al. | Jan 2004 | B2 |
| 6689091 | Bui et al. | Feb 2004 | B2 |
| 6694191 | Starkweather et al. | Feb 2004 | B2 |
| 6694334 | Dulong et al. | Feb 2004 | B2 |
| 6711460 | Reese | Mar 2004 | B1 |
| 6731324 | Levy | May 2004 | B2 |
| 6733447 | Lai et al. | May 2004 | B2 |
| 6735497 | Wallace et al. | May 2004 | B2 |
| 6740075 | Lebel et al. | May 2004 | B2 |
| 6746398 | Hervy et al. | Jun 2004 | B2 |
| 6758810 | Lebel et al. | Jul 2004 | B2 |
| 6768425 | Flaherty et al. | Jul 2004 | B2 |
| 6771369 | Rzasa et al. | Aug 2004 | B2 |
| 6775602 | Gordon, Jr. et al. | Aug 2004 | B2 |
| 6776304 | Liff et al. | Aug 2004 | B2 |
| 6790198 | White et al. | Sep 2004 | B1 |
| 6804656 | Rosenfeld et al. | Oct 2004 | B1 |
| 6810290 | Lebel et al. | Oct 2004 | B2 |
| 6811533 | Lebel et al. | Nov 2004 | B2 |
| 6811534 | Bowman, IV et al. | Nov 2004 | B2 |
| 6811707 | Rovatti et al. | Nov 2004 | B2 |
| 6813473 | Bruker | Nov 2004 | B1 |
| 6813519 | Lebel et al. | Nov 2004 | B2 |
| 6814255 | Liff et al. | Nov 2004 | B2 |
| 6820093 | De La Huerga | Nov 2004 | B2 |
| 6842736 | Brzozowski | Jan 2005 | B1 |
| 6847861 | Lunak et al. | Jan 2005 | B2 |
| 6854088 | Massengale et al. | Feb 2005 | B2 |
| 6871211 | Labounty et al. | Mar 2005 | B2 |
| 6873268 | Lebel et al. | Mar 2005 | B2 |
| 6877530 | Osborne et al. | Apr 2005 | B2 |
| 6880034 | Manke et al. | Apr 2005 | B2 |
| 6885288 | Pincus | Apr 2005 | B2 |
| 6887201 | Bardy | May 2005 | B2 |
| 6892941 | Rosenblum | May 2005 | B2 |
| 6912549 | Rotter et al. | Jun 2005 | B2 |
| 6913590 | Sorenson et al. | Jul 2005 | B2 |
| 6915265 | Johnson | Jul 2005 | B1 |
| 6915823 | Osborne et al. | Jul 2005 | B2 |
| 6928452 | De La Huerga | Aug 2005 | B2 |
| 6950708 | Bowman, IV et al. | Sep 2005 | B2 |
| 6958705 | Lebel et al. | Oct 2005 | B2 |
| 6974437 | Lebel et al. | Dec 2005 | B2 |
| 6975924 | Kircher et al. | Dec 2005 | B2 |
| 6976628 | Krupa | Dec 2005 | B2 |
| 6979306 | Moll | Dec 2005 | B2 |
| 6980958 | Surwit et al. | Dec 2005 | B1 |
| 6981644 | Cheong et al. | Jan 2006 | B2 |
| 6985870 | Martucci et al. | Jan 2006 | B2 |
| 6991002 | Osborne et al. | Jan 2006 | B2 |
| 6995664 | Darling | Feb 2006 | B1 |
| 7006893 | Hart et al. | Feb 2006 | B2 |
| 7015806 | Naidoo et al. | Mar 2006 | B2 |
| 7017622 | Osborne et al. | Mar 2006 | B2 |
| 7017623 | Tribble et al. | Mar 2006 | B2 |
| 7028723 | Alouani et al. | Apr 2006 | B1 |
| 7096212 | Tribble et al. | Aug 2006 | B2 |
| 7117902 | Osborne | Oct 2006 | B2 |
| 7151982 | Liff et al. | Dec 2006 | B2 |
| 7194336 | DiGianfilippo et al. | Mar 2007 | B2 |
| 7209891 | Addy et al. | Apr 2007 | B1 |
| 7240699 | Osborne et al. | Jul 2007 | B2 |
| 7255680 | Gharib | Aug 2007 | B1 |
| 7277579 | Huang | Oct 2007 | B2 |
| 7277757 | Casavant et al. | Oct 2007 | B2 |
| 7317967 | DiGianfilippo et al. | Jan 2008 | B2 |
| 7321861 | Oon | Jan 2008 | B1 |
| 7343224 | DiGianfilippo et al. | Mar 2008 | B2 |
| 7403901 | Carley et al. | Jul 2008 | B1 |
| 7427002 | Liff et al. | Sep 2008 | B2 |
| 7493263 | Helmus et al. | Feb 2009 | B2 |
| 7499581 | Tribble et al. | Mar 2009 | B2 |
| 7509280 | Haudenschild | Mar 2009 | B1 |
| 7555557 | Bradley et al. | Jun 2009 | B2 |
| 7561312 | Proudfoot et al. | Jul 2009 | B1 |
| 7581953 | Lehmann et al. | Sep 2009 | B2 |
| 7599516 | Limer et al. | Oct 2009 | B2 |
| 7610115 | Rob et al. | Oct 2009 | B2 |
| 7630908 | Amrien et al. | Dec 2009 | B1 |
| 7636718 | Steen et al. | Dec 2009 | B1 |
| 7672859 | Louie et al. | Mar 2010 | B1 |
| 7698019 | Moncrief et al. | Apr 2010 | B2 |
| 7698154 | Marchosky | Apr 2010 | B2 |
| 7734478 | Goodall et al. | Jun 2010 | B2 |
| 7753085 | Tribble et al. | Jul 2010 | B2 |
| 7769601 | Bleser et al. | Aug 2010 | B1 |
| 7783383 | Eliuk et al. | Aug 2010 | B2 |
| D624225 | Federico et al. | Sep 2010 | S |
| 7801642 | Ansari et al. | Sep 2010 | B2 |
| 7847970 | McGrady | Dec 2010 | B1 |
| 7853621 | Guo | Dec 2010 | B2 |
| 7904822 | Monteleone et al. | Mar 2011 | B2 |
| 7931859 | Mlodzinski et al. | Apr 2011 | B2 |
| 7937290 | Bahir | May 2011 | B2 |
| 7986369 | Burns | Jul 2011 | B1 |
| 7991507 | Liff et al. | Aug 2011 | B2 |
| 8170271 | Chen | May 2012 | B2 |
| 8191339 | Tribble et al. | Jun 2012 | B2 |
| 8215557 | Reno et al. | Jul 2012 | B1 |
| 8220503 | Tribble et al. | Jul 2012 | B2 |
| 8225824 | Eliuk et al. | Jul 2012 | B2 |
| D667961 | Marmier | Sep 2012 | S |
| 8267129 | Doherty et al. | Sep 2012 | B2 |
| 8271138 | Eliuk et al. | Sep 2012 | B2 |
| 8280549 | Liff et al. | Oct 2012 | B2 |
| 8284305 | Newcomb et al. | Oct 2012 | B2 |
| 8374887 | Alexander | Feb 2013 | B1 |
| 8386070 | Eliuk et al. | Feb 2013 | B2 |
| 8548824 | daCosta | Oct 2013 | B1 |
| 8554579 | Tribble et al. | Oct 2013 | B2 |
| D693480 | Spiess et al. | Nov 2013 | S |
| 8595206 | Ansari | Nov 2013 | B1 |
| 8666541 | Ansari et al. | Mar 2014 | B1 |
| 8678047 | Tribble et al. | Mar 2014 | B2 |
| D715958 | Bossart et al. | Oct 2014 | S |
| 9053218 | Osborne et al. | Jun 2015 | B2 |
| D733480 | Shao | Jul 2015 | S |
| D738152 | Grasselli et al. | Sep 2015 | S |
| D753428 | Shao | Apr 2016 | S |
| 9362969 | Burgess et al. | Jun 2016 | B1 |
| 9382021 | Tribble et al. | Jul 2016 | B2 |
| 9662273 | Ranalletta et al. | May 2017 | B2 |
| 9930297 | Alexander et al. | Mar 2018 | B2 |
| 9956145 | Thompson et al. | May 2018 | B2 |
| 20010001237 | Stroda et al. | May 2001 | A1 |
| 20010003177 | Schena et al. | Jun 2001 | A1 |
| 20010007053 | Bardy | Jul 2001 | A1 |
| 20010007932 | Kamen et al. | Jul 2001 | A1 |
| 20010011153 | Bardy | Aug 2001 | A1 |
| 20010016699 | Burbank et al. | Aug 2001 | A1 |
| 20010017817 | De La Huerga | Aug 2001 | A1 |
| 20010021801 | Bardy | Sep 2001 | A1 |
| 20010025138 | Bardy | Sep 2001 | A1 |
| 20010025156 | Bui et al. | Sep 2001 | A1 |
| 20010027634 | Hebron et al. | Oct 2001 | A1 |
| 20010028308 | De La Huerga | Oct 2001 | A1 |
| 20010030234 | Wiklof | Oct 2001 | A1 |
| 20010031944 | Peterson et al. | Oct 2001 | A1 |
| 20010032101 | Statius Muller | Oct 2001 | A1 |
| 20010034502 | Moberg et al. | Oct 2001 | A1 |
| 20010034614 | Fletcher-Haynes et al. | Oct 2001 | A1 |
| 20010034616 | Giannini | Oct 2001 | A1 |
| 20010037057 | Bardy | Nov 2001 | A1 |
| 20010037083 | Hartlaub et al. | Nov 2001 | A1 |
| 20010037217 | Abensour et al. | Nov 2001 | A1 |
| 20010037220 | Merry et al. | Nov 2001 | A1 |
| 20010041920 | Starkweather et al. | Nov 2001 | A1 |
| 20010044588 | Mault | Nov 2001 | A1 |
| 20010044731 | Coffman et al. | Nov 2001 | A1 |
| 20010047125 | Quy | Nov 2001 | A1 |
| 20010051764 | Bardy | Dec 2001 | A1 |
| 20010053885 | Gielen et al. | Dec 2001 | A1 |
| 20020002326 | Causey, III et al. | Jan 2002 | A1 |
| 20020002473 | Schrier et al. | Jan 2002 | A1 |
| 20020004645 | Carlisle et al. | Jan 2002 | A1 |
| 20020007285 | Rappaport | Jan 2002 | A1 |
| 20020010568 | Rubbert et al. | Jan 2002 | A1 |
| 20020010679 | Felsher | Jan 2002 | A1 |
| 20020013612 | Whitehurst | Jan 2002 | A1 |
| 20020016567 | Hochman et al. | Feb 2002 | A1 |
| 20020016568 | Lebel et al. | Feb 2002 | A1 |
| 20020016719 | Nemeth et al. | Feb 2002 | A1 |
| 20020016722 | Kameda | Feb 2002 | A1 |
| 20020019606 | Lebel et al. | Feb 2002 | A1 |
| 20020019748 | Brown | Feb 2002 | A1 |
| 20020022776 | Bardy | Feb 2002 | A1 |
| 20020025796 | Taylor et al. | Feb 2002 | A1 |
| 20020026104 | Bardy | Feb 2002 | A1 |
| 20020029157 | Marchosky | Mar 2002 | A1 |
| 20020029776 | Blomquist | Mar 2002 | A1 |
| 20020032582 | Feeney et al. | Mar 2002 | A1 |
| 20020032602 | Lanzillo, Jr. et al. | Mar 2002 | A1 |
| 20020038392 | De La Huerga | Mar 2002 | A1 |
| 20020040208 | Flaherty et al. | Apr 2002 | A1 |
| 20020044043 | Chaco et al. | Apr 2002 | A1 |
| 20020046062 | Kameda | Apr 2002 | A1 |
| 20020046185 | Villart et al. | Apr 2002 | A1 |
| 20020046346 | Evans | Apr 2002 | A1 |
| 20020052539 | Haller et al. | May 2002 | A1 |
| 20020052542 | Bardy | May 2002 | A1 |
| 20020052574 | Hochman et al. | May 2002 | A1 |
| 20020062227 | Yuyama | May 2002 | A1 |
| 20020062229 | Alban et al. | May 2002 | A1 |
| 20020065540 | Lebel et al. | May 2002 | A1 |
| 20020065686 | Monteleone et al. | May 2002 | A1 |
| 20020067273 | Jaques et al. | Jun 2002 | A1 |
| 20020072733 | Flaherty | Jun 2002 | A1 |
| 20020073250 | Ommering | Jun 2002 | A1 |
| 20020077852 | Ford et al. | Jun 2002 | A1 |
| 20020077865 | Sullivan | Jun 2002 | A1 |
| 20020082480 | Riff et al. | Jun 2002 | A1 |
| 20020082865 | Bianco et al. | Jun 2002 | A1 |
| 20020082868 | Pories et al. | Jun 2002 | A1 |
| 20020084904 | De La Huerga | Jul 2002 | A1 |
| 20020087120 | Rogers et al. | Jul 2002 | A1 |
| 20020091309 | Auer | Jul 2002 | A1 |
| 20020099283 | Christ et al. | Jul 2002 | A1 |
| 20020099301 | Bardy | Jul 2002 | A1 |
| 20020100762 | Liff et al. | Aug 2002 | A1 |
| 20020107476 | Mann et al. | Aug 2002 | A1 |
| 20020107707 | Naparstek et al. | Aug 2002 | A1 |
| 20020116226 | Auer et al. | Aug 2002 | A1 |
| 20020116509 | De La Huerga | Aug 2002 | A1 |
| 20020128606 | Cowan et al. | Sep 2002 | A1 |
| 20020128871 | Adamson et al. | Sep 2002 | A1 |
| 20020128880 | Kunikiyo | Sep 2002 | A1 |
| 20020133377 | Brown | Sep 2002 | A1 |
| 20020140675 | Ali et al. | Oct 2002 | A1 |
| 20020143254 | Maruyama | Oct 2002 | A1 |
| 20020156462 | Stultz | Oct 2002 | A1 |
| 20020158128 | Ashiuro | Oct 2002 | A1 |
| 20020165491 | Reilly | Nov 2002 | A1 |
| 20020169636 | Eggers et al. | Nov 2002 | A1 |
| 20020173875 | Wallace et al. | Nov 2002 | A1 |
| 20020188467 | Eke | Dec 2002 | A1 |
| 20020198473 | Kumar et al. | Dec 2002 | A1 |
| 20020198513 | Lebel et al. | Dec 2002 | A1 |
| 20020198624 | Greenwald | Dec 2002 | A1 |
| 20030006878 | Chung | Jan 2003 | A1 |
| 20030023177 | Bardy | Jan 2003 | A1 |
| 20030033532 | Marks | Feb 2003 | A1 |
| 20030036783 | Bauhahn et al. | Feb 2003 | A1 |
| 20030046114 | Davies et al. | Mar 2003 | A1 |
| 20030046280 | Rotter et al. | Mar 2003 | A1 |
| 20030046439 | Manke et al. | Mar 2003 | A1 |
| 20030050621 | Lebel et al. | Mar 2003 | A1 |
| 20030050731 | Rosenblum | Mar 2003 | A1 |
| 20030052787 | Zerhusen | Mar 2003 | A1 |
| 20030060753 | Starkweather et al. | Mar 2003 | A1 |
| 20030060754 | Reilly | Mar 2003 | A1 |
| 20030060765 | Campbell et al. | Mar 2003 | A1 |
| 20030060768 | Kiyatake | Mar 2003 | A1 |
| 20030065287 | Spohn et al. | Apr 2003 | A1 |
| 20030076736 | Buker et al. | Apr 2003 | A1 |
| 20030078534 | Hochman et al. | Apr 2003 | A1 |
| 20030079746 | Hickle | May 2003 | A1 |
| 20030083901 | Bosch et al. | May 2003 | A1 |
| 20030088238 | Poulsen et al. | May 2003 | A1 |
| 20030097092 | Flaherty | May 2003 | A1 |
| 20030114836 | Estes et al. | Jun 2003 | A1 |
| 20030117580 | Franz et al. | Jun 2003 | A1 |
| 20030125609 | Becker | Jul 2003 | A1 |
| 20030125611 | Bardy | Jul 2003 | A1 |
| 20030139701 | White et al. | Jul 2003 | A1 |
| 20030144878 | Wilkes et al. | Jul 2003 | A1 |
| 20030149599 | Goodall et al. | Aug 2003 | A1 |
| 20030154108 | Fletcher-Haynes et al. | Aug 2003 | A1 |
| 20030158508 | DiGianfilippo | Aug 2003 | A1 |
| 20030160683 | Blomquist | Aug 2003 | A1 |
| 20030163088 | Blomquist | Aug 2003 | A1 |
| 20030163223 | Blomquist | Aug 2003 | A1 |
| 20030163789 | Blomquist | Aug 2003 | A1 |
| 20030167035 | Flaherty et al. | Sep 2003 | A1 |
| 20030176933 | Lebel et al. | Sep 2003 | A1 |
| 20030179287 | Kozic et al. | Sep 2003 | A1 |
| 20030181851 | Mann et al. | Sep 2003 | A1 |
| 20030182164 | Blomquist | Sep 2003 | A1 |
| 20030195397 | Bardy | Oct 2003 | A1 |
| 20030200117 | Manetta et al. | Oct 2003 | A1 |
| 20030201697 | Richardson | Oct 2003 | A1 |
| 20030212379 | Bylund et al. | Nov 2003 | A1 |
| 20030225596 | Richardson et al. | Dec 2003 | A1 |
| 20030225728 | Moura | Dec 2003 | A1 |
| 20030231803 | Huang | Dec 2003 | A1 |
| 20040002874 | Shaffer et al. | Jan 2004 | A1 |
| 20040017475 | Akers et al. | Jan 2004 | A1 |
| 20040019607 | Moubayed et al. | Jan 2004 | A1 |
| 20040115132 | Brown | Jan 2004 | A1 |
| 20040039260 | Bardy | Feb 2004 | A1 |
| 20040039264 | Bardy | Feb 2004 | A1 |
| 20040051368 | Caputo et al. | Mar 2004 | A1 |
| 20040055611 | Penny et al. | Mar 2004 | A1 |
| 20040064343 | Korpman et al. | Apr 2004 | A1 |
| 20040073329 | Engleson | Apr 2004 | A1 |
| 20040088187 | Chudy et al. | May 2004 | A1 |
| 20040088374 | Webb et al. | May 2004 | A1 |
| 20040105271 | Chen | Jun 2004 | A1 |
| 20040111293 | Firanek et al. | Jun 2004 | A1 |
| 20040116862 | Ray | Jun 2004 | A1 |
| 20040117215 | Marchosky | Jun 2004 | A1 |
| 20040128162 | Schlotterbeck et al. | Jul 2004 | A1 |
| 20040129616 | Mori et al. | Jul 2004 | A1 |
| 20040148195 | Kalies | Jul 2004 | A1 |
| 20040158193 | Bui et al. | Aug 2004 | A1 |
| 20040172283 | Vanderveen et al. | Sep 2004 | A1 |
| 20040172289 | Kozic et al. | Sep 2004 | A1 |
| 20040172300 | Mihai et al. | Sep 2004 | A1 |
| 20040181268 | Anderer | Sep 2004 | A1 |
| 20040193328 | Zaitsu et al. | Sep 2004 | A1 |
| 20040193453 | Butterfield et al. | Sep 2004 | A1 |
| 20040204673 | Flaherty | Oct 2004 | A1 |
| 20040204954 | Lacko | Oct 2004 | A1 |
| 20040215490 | Duchon et al. | Oct 2004 | A1 |
| 20040220829 | Baharav et al. | Nov 2004 | A1 |
| 20040225528 | Brock | Nov 2004 | A1 |
| 20040235446 | Flaherty et al. | Nov 2004 | A1 |
| 20040236630 | Kost et al. | Nov 2004 | A1 |
| 20040248295 | Katsuhiko et al. | Dec 2004 | A1 |
| 20040260233 | Garibotto et al. | Dec 2004 | A1 |
| 20040260577 | Dahlin et al. | Dec 2004 | A1 |
| 20050001033 | Cheong et al. | Jan 2005 | A1 |
| 20050017864 | Tsoukalis | Jan 2005 | A1 |
| 20050033124 | Kelly et al. | Feb 2005 | A1 |
| 20050033773 | Roberge et al. | Feb 2005 | A1 |
| 20050038680 | McMahon | Feb 2005 | A1 |
| 20050039742 | Hickle | Feb 2005 | A1 |
| 20050043665 | Vinci et al. | Feb 2005 | A1 |
| 20050045548 | Brugger et al. | Mar 2005 | A1 |
| 20050054923 | Pan | Mar 2005 | A1 |
| 20050060372 | DeBettencourt et al. | Mar 2005 | A1 |
| 20050080651 | Morrison et al. | Apr 2005 | A1 |
| 20050187794 | Kimak | Aug 2005 | A1 |
| 20050209737 | Kircher | Sep 2005 | A1 |
| 20050228238 | Monitzer | Oct 2005 | A1 |
| 20050279419 | Tribble et al. | Dec 2005 | A1 |
| 20060084042 | Weaver et al. | Apr 2006 | A1 |
| 20060124656 | Popovich, Jr. | Jun 2006 | A1 |
| 20060136095 | Rob et al. | Jun 2006 | A1 |
| 20060149416 | Mohapatra et al. | Jul 2006 | A1 |
| 20060161294 | DiMaggio | Jul 2006 | A1 |
| 20060173714 | Grotzinger, Jr. | Aug 2006 | A1 |
| 20060178578 | Tribble et al. | Aug 2006 | A1 |
| 20060181391 | McNeill et al. | Aug 2006 | A1 |
| 20060235881 | Masarie et al. | Oct 2006 | A1 |
| 20070043767 | Osborne et al. | Feb 2007 | A1 |
| 20070047980 | Limer et al. | Mar 2007 | A1 |
| 20070088568 | Goodall et al. | Apr 2007 | A1 |
| 20070110305 | Corcoran et al. | May 2007 | A1 |
| 20070125442 | Tribble et al. | Jun 2007 | A1 |
| 20070168228 | Lawless | Jul 2007 | A1 |
| 20070179806 | Knowlton et al. | Aug 2007 | A1 |
| 20070189597 | Limer et al. | Aug 2007 | A1 |
| 20070192139 | Cookson et al. | Aug 2007 | A1 |
| 20070216998 | Sander | Sep 2007 | A1 |
| 20070239482 | Finn et al. | Oct 2007 | A1 |
| 20070239997 | Qu et al. | Oct 2007 | A1 |
| 20080046292 | Myers et al. | Feb 2008 | A1 |
| 20080056556 | Eller et al. | Mar 2008 | A1 |
| 20080059228 | Bossi et al. | Mar 2008 | A1 |
| 20080091467 | Moncrief et al. | Apr 2008 | A1 |
| 20080119958 | Bear et al. | May 2008 | A1 |
| 20080125897 | DiGianfilippo et al. | May 2008 | A1 |
| 20080147554 | Stevens et al. | Jun 2008 | A1 |
| 20080195246 | Tribble et al. | Aug 2008 | A1 |
| 20080214333 | Peery | Sep 2008 | A1 |
| 20080306926 | Friedlander et al. | Dec 2008 | A1 |
| 20090024414 | Mansour et al. | Jan 2009 | A1 |
| 20090080408 | Natoli et al. | Mar 2009 | A1 |
| 20090097368 | Vlutters et al. | Apr 2009 | A1 |
| 20090138340 | Borr et al. | May 2009 | A1 |
| 20090157537 | Miller | Jun 2009 | A1 |
| 20090188937 | Kim | Jul 2009 | A1 |
| 20090189988 | Jia | Jul 2009 | A1 |
| 20090205877 | Claypool | Aug 2009 | A1 |
| 20090210252 | Silver | Aug 2009 | A1 |
| 20090235194 | Arndt et al. | Sep 2009 | A1 |
| 20090258331 | Do et al. | Oct 2009 | A1 |
| 20090285762 | Flower | Nov 2009 | A1 |
| 20090313044 | Haque et al. | Dec 2009 | A1 |
| 20090323170 | Lin | Dec 2009 | A1 |
| 20090324032 | Chen | Dec 2009 | A1 |
| 20100017031 | Rob et al. | Jan 2010 | A1 |
| 20100091281 | Suzuki | Apr 2010 | A1 |
| 20100094653 | Tribble et al. | Apr 2010 | A1 |
| 20100128165 | Newcomb et al. | May 2010 | A1 |
| 20100157293 | Rzasa et al. | Jun 2010 | A9 |
| 20100185456 | Kansal | Jul 2010 | A1 |
| 20100241270 | Eliuk et al. | Sep 2010 | A1 |
| 20110090350 | Oomori | Apr 2011 | A1 |
| 20110119088 | Gunn | May 2011 | A1 |
| 20110191121 | Fioravanti | Aug 2011 | A1 |
| 20110202366 | Akers et al. | Aug 2011 | A1 |
| 20110208350 | Eliuk et al. | Aug 2011 | A1 |
| 20110267465 | Alexander et al. | Nov 2011 | A1 |
| 20120097290 | Mikhaeil | Apr 2012 | A1 |
| 20120200596 | Gotou et al. | Aug 2012 | A1 |
| 20120211565 | Colavito | Aug 2012 | A1 |
| 20120303388 | Vishnubhatla et al. | Nov 2012 | A1 |
| 20130079581 | Agamaite et al. | Mar 2013 | A1 |
| 20130090947 | Nockley | Apr 2013 | A1 |
| 20130197445 | Schabbach et al. | Aug 2013 | A1 |
| 20130262138 | Jaskela et al. | Oct 2013 | A1 |
| 20130279774 | Helgason et al. | Oct 2013 | A1 |
| 20130304510 | Chan et al. | Nov 2013 | A1 |
| 20130314535 | Yuyama et al. | Nov 2013 | A1 |
| 20130342676 | Amano | Dec 2013 | A1 |
| 20140022569 | Matsui et al. | Jan 2014 | A1 |
| 20140156064 | Crawford et al. | Jun 2014 | A1 |
| 20140156294 | Tribble et al. | Jun 2014 | A1 |
| 20140214436 | Utech et al. | Jul 2014 | A1 |
| 20140350950 | Jaskela et al. | Nov 2014 | A1 |
| 20150205932 | Tribble | Jul 2015 | A1 |
| 20150227719 | Ranalletta | Aug 2015 | A1 |
| 20150272320 | Ranalletta et al. | Oct 2015 | A1 |
| 20150278477 | Tribble | Oct 2015 | A1 |
| 20150286799 | Padmani | Oct 2015 | A1 |
| 20160072985 | Sandmann et al. | Mar 2016 | A1 |
| 20160092638 | Padmani | Mar 2016 | A1 |
| 20160092639 | Padmani | Mar 2016 | A1 |
| 20160140315 | Diaz et al. | May 2016 | A1 |
| 20160210437 | Padmani et al. | Jul 2016 | A1 |
| 20160371462 | Wallen | Dec 2016 | A1 |
| 20170372034 | Tribble | Dec 2017 | A1 |
| Number | Date | Country |
|---|---|---|
| 1516257 | May 1999 | CN |
| 2440518 | Aug 2001 | CN |
| 1131076 | Dec 2003 | CN |
| 0237588 | Sep 1987 | EP |
| 0462466 | Dec 1991 | EP |
| 0505627 | Sep 1992 | EP |
| 0522527 | Jan 1993 | EP |
| 0439355 | Sep 1994 | EP |
| 0844581 | May 1998 | EP |
| 0960627 | Dec 1999 | EP |
| 0970655 | Jan 2000 | EP |
| 1072994 | Feb 2001 | EP |
| 1107158 | Jun 2001 | EP |
| 1097671 | Feb 2003 | EP |
| 2489343 | Aug 2012 | EP |
| 994977 | Jun 1956 | GB |
| 994977 | Jun 1965 | GB |
| 2210713 | Feb 1987 | GB |
| 2279784 | Jan 1995 | GB |
| 2285135 | Jun 1995 | GB |
| 2379037 | Feb 2003 | GB |
| 53137644 | Dec 1978 | JP |
| 61066950 | Apr 1986 | JP |
| 63068133 | Mar 1988 | JP |
| 2111375 | Apr 1990 | JP |
| 3423055 | Jan 1994 | JP |
| 6086813 | Mar 1994 | JP |
| 06327636 | Nov 1994 | JP |
| 7-204253 | Aug 1995 | JP |
| 07204253 | Aug 1995 | JP |
| 104585 | Jan 1998 | JP |
| 10014890 | Jan 1998 | JP |
| 10079770 | Mar 1998 | JP |
| 2000036032 | Feb 2000 | JP |
| 03055131 | Apr 2000 | JP |
| 2002011095 | Jan 2002 | JP |
| 2002092181 | Mar 2002 | JP |
| 2002520718 | Jul 2002 | JP |
| 2003022322 | Jan 2003 | JP |
| 2004078970 | Mar 2004 | JP |
| 2004326436 | Nov 2004 | JP |
| 2004340770 | Dec 2004 | JP |
| 2005252710 | Sep 2005 | JP |
| 2006033291 | Feb 2006 | JP |
| 2006334062 | Dec 2006 | JP |
| 2006334062 | Dec 2006 | JP |
| 2007151001 | Jun 2007 | JP |
| 2007198934 | Aug 2007 | JP |
| 2008-139201 | Jun 2008 | JP |
| 2008139201 | Jun 2008 | JP |
| 4276654 | Jun 2009 | JP |
| 2009265827 | Nov 2009 | JP |
| 2010056619 | Mar 2010 | JP |
| 2010170504 | Aug 2010 | JP |
| 2010533927 | Oct 2010 | JP |
| 2011151430 | Aug 2011 | JP |
| 2012-078265 | Apr 2012 | JP |
| 2012078265 | Apr 2012 | JP |
| 5342197 | Nov 2013 | JP |
| 5747150 | Jul 2015 | JP |
| 6086813 | Mar 2017 | JP |
| 20000036642 | Jul 2000 | KR |
| 1020000036642 | Jul 2000 | KR |
| 20010094703 | Nov 2001 | KR |
| 1020010094703 | Nov 2001 | KR |
| 20050054379 | Dec 2003 | KR |
| 20110115927 | Oct 2011 | KR |
| 1020110115927 | Oct 2011 | KR |
| 20130001500 | Jan 2013 | KR |
| WO8400493 | Feb 1984 | WO |
| WO9524010 | Sep 1995 | WO |
| WO9634291 | Oct 1996 | WO |
| WO9741525 | Nov 1997 | WO |
| WO9814275 | Apr 1998 | WO |
| WO9815092 | Apr 1998 | WO |
| WO9824358 | Jun 1998 | WO |
| WO9833433 | Aug 1998 | WO |
| WO9859487 | Dec 1998 | WO |
| WO9904043 | Jan 1999 | WO |
| WO9910029 | Mar 1999 | WO |
| WO9942933 | Aug 1999 | WO |
| WO9944162 | Sep 1999 | WO |
| WO9959472 | Nov 1999 | WO |
| WO0013588 | Mar 2000 | WO |
| WO0029983 | May 2000 | WO |
| WO0043941 | Jul 2000 | WO |
| WO0052437 | Sep 2000 | WO |
| WO0052626 | Sep 2000 | WO |
| WO0057339 | Sep 2000 | WO |
| WO0060449 | Oct 2000 | WO |
| WO0069331 | Nov 2000 | WO |
| WO0072181 | Nov 2000 | WO |
| WO0078374 | Dec 2000 | WO |
| WO0101305 | Jan 2001 | WO |
| WO0102979 | Jan 2001 | WO |
| WO0106468 | Jan 2001 | WO |
| WO0145774 | Jun 2001 | WO |
| WO0217777 | Jul 2002 | WO |
| WO02091276 | Nov 2002 | WO |
| WO03025826 | Mar 2003 | WO |
| WO03094073 | Nov 2003 | WO |
| WO2004070557 | Aug 2004 | WO |
| WO2004070994 | Aug 2004 | WO |
| 2012056317 | May 2012 | WO |
| Entry |
|---|
| GE ImageQuant TL 7.0 Image Analysis Sollware User Manual, May 2007, http://nba.uth.tmc.edu/Assets/pdf/other/yphoon_supporting_files/IQTL_UserManual.pdf, Uppsala, Sweden. |
| Parsons, et al., “Digital Media—Can I Change a Graphic's File Size?”, New Perspectives on Computer Concepts—Course Technology, 2011, Cengage Learning, Boston, MA. |
| Phillips, Jon, Associate Director of Telemedicine; “Telepharmacy at Texas Tech,” presented Apr. 30, 2003, published at http://www .ttuhsc.edu/telemedicine/publ cation.htm at least by Jun. 22, 2003 Jun. 22, 2003. |
| Texas Administrative Code, Title 22, Part 15, Ch 291, Rules 20, 36, and 71-74. Feb. 10, 2004. |
| Peterson, Charles D. and Anderson, Jr, Howard C.; “The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities” Feb. 1, 2004. |
| Cato Reference Manual, Support for Trial Version (Abridged), Vienna, May 2004 Jun. 1, 2004. |
| Seifert et al.; “The Training of a Telepharmacist: Addressing the Needs of Rural West Texas,” American Journal of Pharmaceutical Education 2004; 68 (3) Article 60. Jul. 16, 2004. |
| Cato Reference Manual, Vienna, May 2005 May 1, 2005. |
| “The World's First Fully Integrated Workflow Manager for I.V. Rooms”, IntelliFlowRx Brochure, ForHealth Technologies, Inc., United States, May 2008. |
| Baxa Corporation, DoseEdge the Leading Edge in Dose Management, Brochure, published copyright date 2010. |
| Baxa Corporation, Product Catalog 2010-2011, published at least by Sep. 15, 2012, https:l/web.archive.org/Web/20120915210739/http://www.baxa.com/resources/docs/BaxaCatalog.pdf. |
| AHRQ Health Information Technology Program—Update Jun. 2005 Fact Sheet,, http://www.ahrq.gov/research/findings/factsheets/it/hitfact/index.html—3 pages. |
| Albert A. Cook, “An integrated nursing-pharmacy approach to a computerized medication dispensing/administration system,” Hospital Pharmacy, May 1985, pp. 321-325, vol. 20, JB Lippincott Company, Philadelphia, PA. |
| Allan T. Pryor, “Current State of Computer-based Patient Record Systems,” Aspects of the Computer-based Patient Record, 1992, pp. 67-82, Springer-Verlag, New York, NY. |
| Anderson, Howard “A Narrative on the History of the Development of Telepharmacy in North Dakota from the Board of Pharmacy's Perspective Recorded by Excerpts from Board Minutes”, Feb. 2006. |
| Angaran, “Telemedicine and telepharmacy: Current status and future implications”, Am J Health-Syst Pharm, vol. 56, Jul. 15, 1999, pp. 1404-1405. |
| Ann Slone Endo, “Using Computers in Newborn Intensive Care Settings,” American Journal of Nursing, Jul. 1981, pp. 1336-1337. |
| Anonymous, “Chains covet customized pharmacy integration” Drug Store New, Aug 18, 2003, vol. 25, No. 10—p. 73. |
| Automated Dispensing Technologies: Directory of Vendors, http://pharmacyautomation.com/vendors.html, Jun 5, 2003—3 pages. |
| Auto Syringe® AS40A Infusion Pump Technical Manual, 1995, 89 pages, Baxter Healthcare Corporation, Deerfield, IL. |
| Baxa Corporation, DoseEdge the Leading Edge in Dose Management, Brochure, published copyright date 2010—5 pages. |
| Baxa Corporation, Product Catalog 2010-2011, published at least by Sep. 15, 2012, https://web.archive.org/web/20120915210739http://www.baxa.com/resources/docs/BaxaCatalog.pdf (52 pages). |
| Bell Atlantic Healthcare Systems, Inc., court exhibit, StatLan Functions and Features, Specification, release 3.5, dated Nov. 12, 1992, 49 pages. |
| Ben Schneiderman, “Designing the User Interface: Strategies for Effective Human-Computer Interaction,” 2d Ed., 1992, Chapter 5: Direct Manipulation (56 pages), Addison-Wesley Publishing Company. |
| “Block Medical: Growing with Home Infusion Therapy,” taken from Invivo, the Business and Medicine Report, Apr. 1991, pp. 7-9. |
| Bynum et al., “The Effect of Telepharmacy Counseling on Metered-Dose Inhaler Technique among Adolescents with Asthma in Rural Arkansas”, Telemedicine Journal and e-health, vol. 7, No. 3, 2001, Mary AnnLiebert, Inc., pp. 207-218. |
| Cabral, Jr. et al., “Multmedia Systems for Telemedicine Systems for Telemedicine and Their Communications Requirements,” IEEE Communications Magazine Jul. 1996, pp. 20-27. |
| Cardinal Health Introduces Rxe-source(SM) to Address Pharmacist Labor Shortage and Medication Safety Challenges at Hospitals. PR Newswire, Feb. 25, 2003—5 pages. |
| Casey, Michelle M. et al., “Pharmacist Staffing and the Use of Technology in Small Rural Hospitals: Implications for Medication Safety” Upper Midwest Rural Health Research Center, Dec. 2005—51 pages. |
| Charles Safran, M.D. et al., “Computer-Based Support for Clinical Decision Making,” Clinical Computin, vol. 7, No. 5 (1990), pp. 319-322. |
| Clayton M. Curtis, “A Computer-based Patient Record Emerging from the Public Sector: The Decentralized Hospital Computer Program,” First Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1995, pp. 75-132, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
| Clement J. McDonald, M.D. et al, “The Three-Legged Stool: Regenstrief Institute for Health Care,” Third Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1997, pp. 131-158, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
| Clement J. McDonald, M.D. et al., The Regenstrief Medical Record System: 20 Years of Experience in Hospitals, Clinics, and Neighborhood Health Centers,: M.D. Computing, 1992 pp. 206-217, vol. 9, No. 4, Springer-Verlag, New York, NY. |
| Clifton, G. Dennis et al., “Provision of pharmacy services to underserved populations via remote dispensing and two-way videoconferencing” Am J Health-Syst Pharm, vol. 60, Dec. 15, 2003 oe pp. 2577-2582. |
| Dan Murphy, “Nuclear Pharmacy Primer”, Radiation Protection Management, vol. 20, No. 5 (2003), pp. 1-10. |
| Dan Scheraga; “Tech firms answer chain pharmacy's call for productivity,” Drug Store News; Dec. 15, 2003; 25, 17; ProQuest Research Library, p. 31-32. |
| Daniel Andresen et al., “Scalability Issues for High Performance Digital Libraries on the World Wide Web,” Proceedings of ADL '96, 1996, pp. 139-148, IEEE. |
| Daniel J. Nigrin et al., “Glucoweb: A Case Study of Secure, Remote Biomonitoring and Communication,” Proceedings of the 2000, 5 pages, American Medical Informatics Association, Bethesda, MD. |
| Darryl V. Wareham et al., “Combination Medication Cart and Computer Terminal in Decentralized Drug Distribution,” American Journal of Hospital Pharmacy, Jun. 1983, pp. 976-978, vol. 40, American Society of Hospital Pharmacists. |
| Dart, Luann, “Digital Doses” Rural Electric, Jan. 2005—pp. 28-31. |
| Deborah J. Mayhew, “Principles and Guidelines in Software user Interface Designs,” 1992, selected portions of Chapter 9, 17 pages, Prentice- Hall, Inc. |
| Defendants Initial Invalidity Contentions with Exhibits A and B dated Sep. 8, 2014; Civil Action No. 1:14-cv-00222. |
| Dennis D. Cote et al., “Robotic system for i.v. antineoplastic drug preparation: Description and preliminary evaluation under simulated conditions,” American Journal of Hospital Pharmacy, Nov. 1989, pp. 2286-2293, vol. 46, American Society of Hospital Pharmacists. |
| Donna Young; “Loan repayments help pharmacists provide care in medically underserved areas,” American Journal of Health-System Pharmacy; Nov. 1, 2003, pp. 2186-2188, vol. 60. |
| Environmental Scan of Pharmacy Technicians; M. MacInnis; Canadian Pharmacists Association; Sep. 2001. |
| Exhibit 1, Publications Manually Reviewed for the Search to U.S. Pat. No. 8,347,887 titled “System and Method for Remotely Supervising and Verifying Pharmacy Functions” As of Jun. 25, 2014. |
| Exhibit 1001 U.S. Pat. No. 8,374,887, Alexander issued Feb. 12, 2013. |
| Exhibit 1005, 22 TAC §§291.20, 291.36, and 291.71-291.74 date issued Mar. 5, 2015 from U.S. Pat. No. 8,374,887. |
| Exhibit 1006 U.S. Pat. No. 6,711,460 Reese issued Mar. 23, 2004 from U.S. Pat. No. 8,374,887. |
| Exhibit 1009, Peterson et al., The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities; the journal of Pharmacy Technology, vol. 20, No. 1, Jan./Feb. 2004- pp. 1-39 from U.S. Pat. No. 8,374,887. |
| Exhibit 1011, Complaint—Alexander v. Baxter, (W.D.Texas 2014) filed Mar. 13, 2014 from U.S. Pat. No. 8,374,887. |
| Exhibit 1012, Charles F. Seifert et al., “The Training of a Telepharmacist: Addressing the Needs of Rural West Texas,” American Journal of Pharmaceutical Education, 2004; 68 (3) Article 60—pp. 1-9 from U.S. Pat. No. 8,374,887. |
| Exhibit 1017, Declaration of Dr. Roger W. Anderson in Support of Becton, Dickinson & Company's Response to Baxter's Motion for Summary Judgment of Invalidity Based Upon 35 U.S.C. § 101 filed Jan. 15, 2015 from U.S. Pat. No. 8,374,887. |
| Exhibit 1018, Plaintiff's Claim Construction Brief, 1:14-cv-222-LY filed Oct. 17, 2014 from U.S. Pat. No. 8,374,887. |
| Exhibit 1019, Plaintiff's Reply Claim Construction Brief, 1:14-cv-222-LY filed Nov. 7, 2014 from U.S. Pat. No. 8,374,887. |
| Exhibit 1020, The United States Pharmacopeia—the Official Compendia of Standards; 2004 from U.S. Pat. No. 8,374,887. |
| Exhibit 1023, Charles D Peterson et al., “The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities,” J Pharm Technol, 2004; vol. 20—pp. 028-039 from U.S. Pat. No. 8,374,887. |
| Exhibit 1025, Affidavit of Christopher Butler with attached Telemedicine Report Archive dated Mar. 4, 2015—6 pages from U.S. Pat. No. 8,374,887. |
| Exhibit 1026, Affidavit of Christopher Butler with attached presentation Telepharmacy at Text Tech—Jon Phillips dated Mar. 4, 2015—31 pages from U.S. Pat. No. 8,374,887. |
| Exhibit 1027, Order on Motion for Summary Judgment filed Aug. 3, 2015 from U.S. Pat. No. 8,374,887. |
| Exhibit 1028, Final Judgment filed Aug. 3, 2015 from U.S. Pat. No. 8,374,887. |
| Exhibit 1030 Deposition of Charles Seifert Dec. 4, 2015 from U.S. Pat. No. 8,374,887. |
| Exhibit 1031 Deposition of Diane B. Ginsburg, PhD. Dec. 16, 2015 from U.S. Pat. No. 8,374,887. |
| Exhibit 1032 Texas Administrative Code, Title 22, Chapter 291, Subchapter A, Section 291.23 as in effect on Feb. 1, 2004 from U.S. Pat. No. 8,374,887. |
| Felkey, Bill G., “Integrating Technology at the Point of Care”, Insight, Jan. 2004—pp. 8-10. |
| Formula for Patient Safety; ScriptPro; Aug. 17, 2003. |
| Fred Puckett, “Medication-management component of a point-of-care information system,” Am. J. Health-Syst.Pharm., Jun. 15, 1995, pp. 1305-1309, vol. 52, American Society of Health-System Pharmacists, Inc. |
| “GE ImageQuant TL 7.0 Image Analysis Software” User Manual , May 2007, http://nba.uth.tmc.edu/Assets/pdf/other/typhoon—supporting—files/IQTL—UserManual.pdf, Uppsala, Sweden. |
| Gerald E. Meyer et al., “Use of bar codes in inpatient drug distribution,” Am. J. Hosp. Pharm., May 1991, pp. 953-966, vol. 48, American Society of Hospital Pharmacists, Inc. |
| Ghent, Natale, “Pharmacists go digital to fight shortage”, Pharmacy Practice 20.11 (Nov. 2004): 47—2 pages. |
| Gilad J. Kuperman, M.D. et al., “Innovations and research review: The impact of the HELP computer system on the LDS Hospital paper medical record,” Topics in Health Record Management, 1991, pp. 76-85, vol. 12, Issue 2, Aspen Publishers, Inc. |
| “Global Med Announces First Safetrace TX™ Sale,” Apr. 1, 1999, 2 pages. |
| Global Med Technologies, Inc. Introduces PeopleMed™.com, inc., a Chronic Disease Management Application Service Provider (ASP) Subsidiary, Jan. 11, 2000, 2 pages, Global med Technologies, Inc., Denver, CO. |
| Gretchen A. Barry et al., “Bar-code technology for documenting administration of large-volume intravenous solutions,” American Journal of Hospital Pharmacy, Feb. 1989, pp. 282-287, vol. 46, American Society of Hospital Pharmacists. |
| H. Paul Hammann et al., “A World Wide Web Accessible Multi-Species ECG Database,” 1997, pp. 7-12, ISA. |
| Henry J. Lowe et al., “WebReport: A World Wide Web Based Clinical Multimedia Reporting System,” 1996, pp. 314-318, Amia, Inc. |
| “Hospitals battle errors with bar codes,” Mar. 24, 2004, 3 pages, MSNBC. |
| Howard L. Bleich et al., “Clinical Computing in a Teaching Hospital,” Use and Impact of Computers in Clinical Medicine, 1987, pp. 205-223 and selected pages, Springer-Verlag, New York, NY. |
| http://isorx.com/ Jan. 29, 2004. |
| http://www.scriptpro.com/products//sp-200/main.htm, Feb. 13, 2004, Product listing for SP 200® Robotic Prescription Dispensing System. |
| http://www.scriptpro.com/products/space/space200.htm, Feb. 10, 2004, Product listing for SP Automation Center 200TM (Space 200TM) Prescription Dispensing Automation Center. |
| Hughes, Shirley, “Bedside Terminals: Clinicom,” Clinical Computing, Jan./Feb. 1988, pp. 22-28, vol. 5, No. 1. |
| IPR Decision Paper No. 8 Entered Aug. 13, 2015 from U.S. Pat. No. 8,374,887. |
| IPR Final Written Decision Paper No. 29 Entered Jul. 11, 2016 from U.S. Pat. No. 8,374,887. |
| James Kazmer et al., “The Creation of Virtual Electronic Medical Record,” 1996, 17 pages. |
| Jennifer Langham; “Taking Automation to New Levels,” Insight, the QS/1 Magazine, Oct. 2002; pp. 2-5. |
| John Frady; “What's New in RxCare Plus 17.2,” Insight, the QS/1 Magazine, Apr. 2002; pp. 2-3, 14. |
| Jones, et al., “Use of a remote computerized system for study documentation in clinical trials” Drug Information Journal, Oct.-Dec. 1998, vol. 32, No. 4 oe pp. 1153-1163. |
| Karen E. Bradshaw et al., “Physician decision-making—Evaluation of data used in a computerized ICU,” International Journal of Clinical Monitoring and Computing, 1984, pp. 81-91, vol. 1, Martinus Nijhoff Publishers, Netherlands. |
| Kastango, Eric S. and Bradshaw, Brian D., “USP chapter 797: Establishing a practice standard for compounding sterile preparations in pharmacy” Am J Health-Syst Pharm., Sep. 15, 2004, vol. 61—pp. 1928-1938. |
| Kenneth N. Barker et al., “Effect of an automated bedside dispensing machine on medication errors,” American Journal of Hospital Pharmacy, Jul. 1984, pp. 1352-1358, vol. 41, No. 7, American Society of Hospital Pharmacists. |
| Keeys, Christopher A. et al., “Providing nighttime pharmaceutical services through telepharmacy” Am J Health-Syst Pharm, Apr. 15, 2002, vol. 59—pp. 716-721. |
| Khan, Shamima et al., “Is There a Successful Business Case for Telepharmacy?” Telemedicine and e-Health, vol. 14, No. 3, Apr. 2008, pp. 235-245. |
| Kimber, Michael B. et al., “Telepharmacy-Enabling Technology to Provide Quality Pharmacy Services in Rural and Remote Communities” Journal of Pharmacy Practice and Research, vol. 36, No. 2, 2006—128-133. |
| Kosub, David, “Device allows pharmacy care in remote areas” Pharmacy Practice, vol. 20, No. 10, Oct. 2004—pp. 12-13. |
| Koutnik, Eileen, Assistnat Editor, Pharmacy Times, “The Pharmacy of Tomorrow” Pharmacy Times, Aug. 1, 2003—3 pages. |
| Larry B. Grandia, B.S.E. et al., “Building a computer-based Patient Record System in an Evolving Integrated Health System,” First Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1995, pp. 19-55, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
| Lefkowitz, Sheldon et al., “A Trial of the Use of Bar Code Technology to Restructure a Drug Distribution and Administration System,” 1991, pp. 239-242, Hospital Pharmacy, vol. 26. |
| LP, “ATM-STyle Drug Dispensers Taking Hold in Areas With Limited Pharmacist Services” Pharmacy Practice News, Jan. 2004, vol. 31, No. 1—4 pages. |
| “The Longitudinal Clinical Record: A View of the Patient,” taken from Proceedings of the 1994 Annual HIMSS Conference, Feb. 14, 1994, pp. 239-250, Healthcare Information and Management Systems Society, Chicago, Illinois, USA. |
| Lustig, Ahuva, “Medication error prevention by pharmacists—an Israeli solution” Pharmacy World & Science, 2000, vol. 22, No. 1—pp. 21-25. |
| Medicaid Memo—Department of Medical Assistance Services (Converting NDCs from 10-digits to 11-digits) May 31, 2007. |
| Michael H. MacKin, “Impact of Technology on Environmental Therapeutic Device Design,” Medical Instrumentation, Feb. 1987, pp. 33-35, vol. 21, No. 1, Association for the Advancement of Medical Instrumentation. |
| Michelle M. Casey, M.S., Jill Klingner, R.N., M.S., and Ira Moscovice, Ph.D.; “Access to Rural Pharmacy Services in Minnesota, North Dakota, and South Dakota,” Working Paper Series, Jul. 2001, #36. |
| Monane et al., “Improving Prescribing Patterson for the Elderly Through an Online Drug Utilization Review Intervention”, JAMA, Oct. 14,1998, vol. 280, No. 14—pp. 1249-1252. |
| Morris, Aisha M., Schneider, Philip J., Pedersen, Craig A. and Mirtallo, Jay M. “National survey of quality assurance activities for pharmacy-compounded sterile preparations” Am J Health-Syst Pharm, Dec. 15, 2003, vol. 60—pp. 2567-2576. |
| Murray, Michael D. et al. “Effects of Computer-based Prescribing on Pharmacist Work Patterns” Journal of the American Medical Informatics Association, Nov./Dec. 1998, vol. 5, No. 6—pp. 546-553. |
| Napoli, M. et al., “Picture archiving and communication in radiology”, Rays. Jan.-Mar. 2003—PubMed—NCBI http://www.ncbi.nlm.m=nih.gov/pubmed/14509181—Abstract. |
| Nissen et al., Can telepharmacy provide pharmacy services in the bush, School of Pharmacy, University of Queensland, Brisbane, Australia, Journal of Telemedicine and Telecare 2003, vol. 9 (Suppl. 2): S2:39-41. |
| Parks, Liz, “Annual report of retail pharmacy: Using central-fill to maximize dispensing” Drug Store News, Aug. 20, 2001 vol. 24, No. 11—pp. 51, 75. |
| Paul H. Perlstein et al., “Computer-Assisted Newborn Intensive Care,” Pediatrics, Apr. 1976, pp. 494-501, vol. 57, No. 4, American Academy of Pediatrics, Inc., Evanston, Illinois. |
| Paul H. Perlstein et al., “Future Directions for Device Design and Infant Management,” Medical Instrumentation, Feb. 1987, pp. 36-41, vol. 21, No. 1, Association for the Advancement of Medical Instrumentation. |
| PCA II Multi-Mode Cartridge Operator's Manual, Sep. 1995, approx. 40 pages, Baxter Healthcare Corporation, Deerfield, IL. |
| Pesce, James, “Bedside Terminals: Medtake,” Clinical Computing, Jan. /Feb. 1988, pp. 16-21, vol. 5, No. 1. |
| Peter Lord et al., MiniMed Technologies Programmable Implantable Infusion System, Annals New York Academy of Science, pp. 66-71, describing clinical trials from Nov. 1986. |
| Pharmacy Data Management (PDM) Technical Manual/Security Guide Version 1.0, Sep. 1997—55 pages. |
| Pharmacy education and practice out of sync? (Roundtable) Chain Drug Review, vol. 25, No. 6, Mar. 17, 2003, RX2 (6). |
| Prem S. Chopra, Virgil A. Thomason, and Dell M. Stinett; “Voice-Activated Networked Workstation for a Physically Disabled Physician,” Oct. 7803-2050-6/94 1994 IEEE, pp. 478-479. |
| Product literature, Baxter Healthcare Corporation, “Flo-Gard® 6201 Volumetric Infusion Pump,” 1992, 2 pages. |
| Product literature, Baxter Healthcare Corporation, “MultiPlex™ Series 100 Fluid Management System,” 1988, 2 pages. |
| Remote Dispensing Regulations, NABPLAW Sep. 2003. |
| Woodall, Sandra C., Remote Order Entry and Video Verification; Reducing After-Hours Medication Errors in a Rural Hospital; S. Woodall; Joint Commission on Accreditation of Healthcare Organizations; vol. 30; No. 8; Aug. 2004. |
| Rich Muller; “NRx QS/1's Premium Pharmacy Software,” Insight, the QS/1 Magazine, Jul. 2003; pp. 2-3, 12-15. |
| Rouse, et al., Academy of Managed Care Pharmacy et al., “White paper on pharmacy technicians 2002: Needed changes can no longer wait” Am J Health-Syst Pharm, Jan. 1, 2003, vol. 60—pp. 37-51. |
| Standard Specification for Transferring Clinical Laboratory Data Messages Between Independent computer Systems, Annual Book of ASTM Standards, Mar. 25, 1988, pp. 1-16, E 1238-88, Global Engineering Documents, Philadelphia, PA. |
| Standard Specification for Transferring Clinical Observations Between Independent Computer Systems, Annual Book of ASTM Standards, Jun. Mar. 1994, pp. 132-210, E 1238-94, Philadelphia, PA. |
| Standard Specification for Transferring Clinical Observations Between Independent Computer Systems, Aug. 10, 1997, 79 pages, ASTM E 1238-97, West Conshohocken, PA, United States. |
| Standard Specification for Transferring Information Between Clinical Instruments and Computer Systems, Annual Book of ASTM Standards, Jun. 1991, 15 pages, E 1394-91, Philadelphia, PA. |
| Suzanne Carter, RN, Ed.D. et al., “The Computer-based Patient Record: The Jacobi Medical Center Experience,” Second Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1996, pp. 71-95, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
| T. Allan Pryor et al., “help—a Total Hospital Information System,” Proceedings of the Fourth Annual Symposium on Computer Applications in Medical Care, Nov. 2-5 1980, pp. 3-7, vol. 1, Institute for Electrical and Electronics Engineers, New York, NY. |
| T.E. Bozeman et al., “The Development and Implementation of a Computer-Based Patient Record in a Rural Integrated Health System,” Third Annual Nicholas E. David Award Proceedings of the CPR Recognition Symposium, 1997, pp. 101-130, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
| “Telepharmacy project expands students' practice experience” Telemedicine Report, vol. 6, No. 1, Jan. 2004 oe 4 pages. |
| Title 22. Examining Boards, 22 TAC Section 1.161; texinfo.library.unt.edu/Texasregister/html/2001/sep-14/PROPOSED/22.EXAMING BOARDS.html—Sep. 20, 2014, pp. 1-70. |
| Ukens, Carol, “Pharmacist shortage boosts telepharmacy” Drug Topoics, Jun. 3, 2002; 146, 11—p. 53. |
| Valeriy Nenov et al., “Remote Analysis of Physiological Data from Neurosurgical ICU Patients,” Journal of the American Medical Informatics Association, Sep./Oct. 1996, pp. 318-327, vol. 3, No. 5. |
| “Victor J. Perini et al., “”Comparison of automated medication-management systems,: Am. J. Hosp. Pharm., Aug. 1, 1994, pp. 1883-1891, vol. 51, American Society of Hospital Pharmacists, Inc.” |
| Vincenzo Della Mae et al., “HTML generation and semantic markup for telepathology,” Computer Networks and ISDN Systems, 1996, pp. 1085-1094, vol. 28, Elsevier Science B.V. |
| Website information for Cartharsis Medical Technology Products, Dec. 9, 2001, 15 pages. |
| Website information for MedPoint™, Mar. 13, 2003, 20 pages, Bridge Medical, Solana Beach, CA. |
| William R. Dito et al., “Bar codes and the clinical laboratory: adaptation perspectives,” Clinical Laboratory Management Review, Jan./Feb. 1992, pp. 72-85, Clinical Laboratory Management Association, Inc. |
| Wills, Robert D., “Drug Images and Drug Imprints” Insight, Apr. 2001—p. 7. |
| Yvonne Mari Abdoo, “Designing a Patient Care Medication and Recording System that Uses Bar Code Technology,” Computers in Nursing, May/Jun. 1992, pp. 116-120, vol. 10, No. 3. |
| Jon Phillips, Telepharmacy at Texas Tech, PowerPoint, Jan. 26, 1997, https://web.archive.org/web/20040509162423/http:/www.ttuhsc.edu/telemedicine/Powerpoint/Telepharmacy%20presentation%2042503.ppt. |
| A.H. McMorris et al. “Are Process Control Rooms Obsolete?”, Control Engineering, pp. 42-47, Jul. 1971. |
| Standard Specification for Transferring Clinical Observations between Indepdendent Computer Systems, Annual Book of ASTM Standards, Nov. 14, 1991, pp. 1-64, ASTM E 1238-91,Philadelphia, PA. |
| Standard Specification for Transferring Information Between Clinical Instruments and Computer Systems, Dec. 10, 1997; 15 pages, ASTM E 1394-97, West Conshohocken, PA, United States. |
| Web site information, Information Data Management, Inc.'s PCMS: Plasma Center Management System, Dec. 14, 2001, 11 pages. |
| Specification for Low-Level Protocol to Transfer Messages Between Clinical Laboratory Instruments and Computer Systems, Mar. 11, 1991; 7 pages, ASTM E 1381-91, Philadelphia, PA, United States. |
| Atherton, H.D., Dollberg, S., Donnelly, M.M., Perlstein, P. H. Roath, S.B., “Computerized Temperature Control of the Low-Birth-Weight Infant: A 20-Year Retrospective and Future Prospects,” Biomedical Instrumentation and Technology, Jul./Aug. 1994, pp. 302-309, vol. 28 No. 4. |
| Friesdorf, W., Grob-Alltag, F., Konichezky, S., Schwilk, B., Fattroth, A., Fett, P., “Lessons learned while building an integrated ICU workstation,” International Journal of Clinical Monitoring and Computing, 1994, pp. 89-97, vol. 11. |
| Gammon, K., Robinson, K., “Bedside Data System Aids Pharmacy,” Computers in Healthcare, Dec. 1988, pp. 35-37, vol. 9 No. 12. |
| Kampmann, J., Lau, G., Kropp, St., Schwarzer, E., Hernandez Sande, C., “Connection of electronic medical devices in ICU according to the standard ‘MIB’,” International Journal of Clinical Monitoring and Computing, 1991, pp. 163-166, vol. 8. |
| Angaran, “Telemedicine and telepharmacy: Current status and future implications”, Am J Health-Syst Pharm, vol. 56, Jul. 15, 1999 (32 pages). |
| Carson, Ewart et al., “A Systems Methodology for the Development and Evaluation of a Telematic Home Haemodialysis Service,” Proceedings—19th International Conference—IEEE/EMBS Oct. 30-Nov. 2, 1997, Chicago, Illinois, pp. 907-910. |
| Extended European Search Report dated Feb. 2, 2019, issued in related European Patent Application No. 18200417.6; 7 Pages. |
| Australian Examination Report for related Australian Application No. 2019208270; action dated Feb. 7, 2020; (6 pages). |
| Number | Date | Country | |
|---|---|---|---|
| 20180311107 A1 | Nov 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61719256 | Oct 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15193494 | Jun 2016 | US |
| Child | 16027805 | US | |
| Parent | 14438559 | US | |
| Child | 15193494 | US |
